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The last few years have witnessed a rapid increase in our knowledge of the retinoid-related orphan receptors
RORα, -β, and -γ (NR1F1-3), their mechanism of action, physiological functions, and their potential role in
several pathologies.The characterization of ROR-deficient mice and gene expression profiling in particular
have provided great insights into the critical functions of RORs in the regulation of a variety of physiological
processes.These studies revealed that RORα plays a critical role in the development of the cerebellum, that
both RORα and RORβ are required for the maturation of photoreceptors in the retina, and that RORγ is essential
for the development of several secondary lymphoid tissues, including lymph nodes. RORs have been further
implicated in the regulation of various metabolic pathways, energy homeostasis, and thymopoiesis. Recent
studies identified a critical role for RORγ in lineage specification of uncommitted CD4
+T helper cells into Th17
cells. In addition, RORs regulate the expression of several components of the circadian clock and may play
a role in integrating the circadian clock and the rhythmic pattern of expression of downstream (metabolic)
genes. Study of ROR target genes has provided insights into the mechanisms by which RORs control these
processes. Moreover, several reports have presented evidence for a potential role of RORs in several
pathologies, including osteoporosis, several autoimmune diseases, asthma, cancer, and obesity, and raised
the possibility that RORs may serve as potential targets for chemotherapeutic intervention.This prospect
was strengthened by recent evidence showing that RORs can function as ligand-dependent transcription
factors.
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Introduction
The cloning of several steroid hormone receptors in the
1980s led to an intense search by many laboratories for
additional, novel members of the steroid hormone
superfamily [Aranda and Pascual, 2001; Desvergne and
Wahli, 1999; Escriva et al., 2000; Evans, 1988; Giguere,
1999; Kumar and Thompson, 1999; Novac and Heinzel,
2004;Willy and Mangelsdorf, 1998].This resulted in the
identification of a number of orphan receptors, including
members of the retinoid-related orphan receptor (ROR)
subfamily, which consists of RORα (NR1F1, RORA or
RZRα)[Becker-Andre et al., 1993; Giguere et al., 1995;
Giguere et al., 1994], RORβ (NR1F2, RORB or RZRβ)
[Andre et al., 1998b; Carlberg et al., 1994;
Schaeren-Wiemers et al., 1997], and RORγ (NR1F3,
RORC or TOR) [He et al., 1998; Hirose et al., 1994;
Medvedev et al., 1996; Ortiz et al., 1995; Sun et al., 2000].
ROR genes have been cloned from several mammalian
species [Becker-Andre et al., 1993; Carlberg et al., 1994;
Giguere et al., 1994; He et al., 1998; Hirose et al., 1994;
Jetten and Joo, 2006; Koibuchi and Chin, 1998;
Medvedev et al., 1996; Ortiz et al., 1995] and zebrafish
[Flores et al., 2007]. ROR orthologues have also been
identified in several lower species, including Drosophila
hormone receptor 3 (DHR3) in Drosophila melanogaster
[Carney et al., 1997; Gates et al., 2004; Horner et al.,
1995; Koelle et al., 1992; Sullivan and Thummel, 2003;
Thummel, 1995], CHR3 in Caenorhabditis elegans
[Kostrouch et al., 1995; Palli et al., 1997; Palli et al.,
1996], and MHR3 in Manduca sexta [Hiruma and
Riddiford, 2004; Lan et al., 1999; Lan et al., 1997;
Langelan et al., 2000; Palli et al., 1992; Riddiford et al.,
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knowledge of RORs, with emphasis on recent
developments in their physiological functions, roles in
pathophysiological processes, and their potential as
pharmatherapeutical targets.
ROR structure and activity
ROR gene structure
The RORα gene maps to human chromosome 15q22.2
and spans a relatively large 730 kb genomic region
comprised of 15 exons.The RORβ and RORγ genes map
to 9q21.13, and 1q21.3 and cover approximately 188 and
24 kb, respectively. As a result of alternative promoter
usage and exon splicing, each ROR gene generates
several isoforms that differ only in their amino-terminus
[Andre et al., 1998b; Giguere et al., 1994; Hamilton et al.,
1996; He et al., 1998; Hirose et al., 1994;
Matysiak-Scholze and Nehls, 1997; Medvedev et al.,
1996; Sun et al., 2000;Villey et al., 1999] (Figure 1). Four
human RORα isoforms, referred to as RORα1-4, have
been identified, while only two isoforms, α1 and α4, have
been reported for mouse.The mouse RORβ gene
generates two isoforms, β1 and β2, while humans appear
to express only the RORβ1 isoform [Andre et al., 1998b].
Both the mouse and human RORγ gene generate two
isoforms, γ1 and γ2 [He et al., 1998; Hirose et al., 1994;
Medvedev et al., 1996;Villey et al., 1999]. Most isoforms
exhibit a distinct pattern of tissue-specific expression and
are involved in the regulation of different physiological
processes and target genes. For example, human RORα3
is only found in human testis [Steinmayr et al., 1998].
RORα1 and RORα4 are both prominently expressed in
mouse cerebellum, while other mouse tissues express
predominantly RORα4 [Chauvet et al., 2002; Hamilton
et al., 1996; Matysiak-Scholze and Nehls, 1997]. RORγ2,
most commonly referred to as RORγt, is exclusively
detected in a few distinct cell types of the immune system,
while RORγ1 expression is restricted to several other
tissues [Eberl et al., 2004; He et al., 1998; Hirose et al.,
1994; Kang et al., 2007]. In the mouse, expression of
RORβ2 is restricted to the pineal gland and the retina,
while RORβ1 is the predominant isoform in cerebral
cortex, thalamus, and hypothalamus [Andre et al., 1998b].
Although most ROR isoforms are under the control of
different promoters, little is known about the transcriptional
regulation of their tissue-specific expression.
ROR protein structure
The ROR genes encode proteins of 459 to 556 amino
acids (Figure 1). RORs exhibit a typical nuclear receptor
domain structure consisting of four major functional
domains: an N-terminal (A/B) domain followed by a highly
conserved DNA-binding domain (DBD), a hinge domain,
and a C-terminal ligand-binding domain (LBD) [Evans,
1988; Giguere, 1999; Jetten et al., 2001; Moras and
Gronemeyer, 1998; Pike et al., 2000; Steinmetz et al.,
2001;Willy and Mangelsdorf, 1998]. RORs regulate gene
transcription by binding to specific DNA response
elements (ROREs), consisting of the consensus RGGTCA
core motif preceded by a 6-bp A/T-rich sequence, in the
regulatory region of target genes [Andre et al., 1998a;
Carlberg et al., 1994; Giguere et al., 1994; Greiner et al.,
1996; Jetten et al., 2001; Medvedev et al., 1996; Moraitis
and Giguere, 1999; Ortiz et al., 1995; Schrader et al.,
1996]. RORs bind ROREs as a monomer and do not form
heterodimers with retinoid-X receptors (RXRs) [Andre et
al., 1998b; Carlberg et al., 1994; Giguere et al., 1994;
Greiner et al., 1996; Medvedev et al., 1996; Moraitis and
Giguere, 1999; Ortiz et al., 1995; Schrader et al., 1996]
(Figure 2).The interaction of RORs with ROREs is
mediated by the P-box, the loop between the last two
cysteines within the first zinc finger, which recognizes the
core motif in the major groove, and the C-terminal
extension, a 30 residue region just downstream from the
two zinc fingers, which interacts with the 5’-AT-rich
segment of the RORE in the adjacent minor groove
[Andre et al., 1998b; Giguere et al., 1995; Giguere et al.,
1994; Jetten et al., 2001; McBroom et al., 1995; Sundvold
and Lien, 2001;Vu-Dac et al., 1997]. Although RORα-γ
and their different isoforms recognize closely-related
ROREs, they exhibit distinct affinities for different ROREs.
The amino-terminus (A/B domain) has been shown to
play a critical role in conferring DNA binding specificity
to the various ROR isoforms [Andre et al., 1998b; Giguere
et al., 1995; Giguere et al., 1994; Sundvold and Lien,
2001;Vu-Dac et al., 1997]. In addition to the RORE
sequence and the amino terminus, the promoter context
may play an important factor in determining which ROR
is recruited to a particular RORE.
In several instances, crosstalk between nuclear receptor
pathways involves competition between receptors for
binding to the same response element. Such an interplay
has been demonstrated between RORs and the nuclear
receptors REV-ERBAα and REV-ERBβ (NR1D1 and D2,
respectively), which recognize a subset of ROREs [Burris,
2008; Giguere et al., 1995]. Because REV-ERB receptors
act as transcriptional repressors, they are able to inhibit
ROR-mediated transcriptional activation by competing
with RORs for RORE binding [Austin et al., 1998;
Bois-Joyeux et al., 2000; Downes et al., 1996; Forman
et al., 1994; Liu et al., 2007b; Medvedev et al., 1997;
Retnakaran et al., 1994] (Figure 2). Positive and negative
regulation of RORE-mediated gene transcription by RORs
and REV-ERBs have been reported to play a role in the
control of brain and muscle ARNT-like 1 (BMAL1 or
ARNTL) expression and may be part of several other
regulatory feedback loops [Akashi and Takumi, 2005;
Albrecht, 2002; Gachon et al., 2004; Guillaumond et al.,
2005; Nakajima et al., 2004; Preitner et al., 2002;
Triqueneaux et al., 2004].
The LBDs of nuclear receptors are multifunctional and
play a role in ligand binding, nuclear localization, receptor
dimerization, and provide an interface for the interaction
with coactivators and corepressors. X-ray structural
analysis demonstrated that RORs have a secondary
domain structure that is characteristic of that of nuclear
receptors [Kallen et al., 2002; Stehlin-Gaon et al., 2003;
Stehlin et al., 2001].The LBDs of RORs contain, in
addition to the typical 12 canonical α-helices (H1-12), two
additional helices, H2’ and H11’.The activation function
2 (AF2) in H12 consists of PLYKELF, which is 100%
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Review Physiological functions of RORsFigure 1.  Schematic representation of ROR family members. Schematic structure of the various human (h) and mouse (m) ROR isoforms.The
DNA binding domain (DBD) and ligand binding domain (LBD), and activation function 2 (AF2) are indicated.The variable regions at the N-terminus of
each ROR generated by alternative promoter usage and/or alternative slicing are indicated by patterned boxes on the left.The numbers on the right
refer to the total number of amino acids in RORs.The different ROR isoforms identified in human and mouse are shown on the right (+/-).
conserved among RORs (Figure 1). Deletion of the H12
or point mutations within H12 causes loss of the ROR
transactivation activity and results in a dominant-negative
ROR [Kurebayashi et al., 2004; Lau et al., 1999]. It is
believed that H10 plays a critical role in the homo- and
heterodimerization of nuclear receptors. Structure
analyses revealed the presence of a kink in H10 of the
LBD of RORα and RORβ that would greatly affect the
dimerization capability of RORs [Kallen et al., 2002;
Stehlin-Gaon et al., 2003; Stehlin et al., 2001].This is
consistent with the conclusion that RORs do not form
homodimers or heterodimers with other RORs or RXRs.
RORs: ligand-dependent transcription factors
Crystallography provided not only insights into the
structure of the LBD, but also into size of the ligand
binding pockets of RORs [Kallen et al., 2002; Stehlin et
al., 2001].The ligand-binding pocket of RORβ was
calculated to be 766 Å
3, similar to that of RORα (722 Å
3).
Homology modeling predicted that the ligand binding
pocket of RORγ is similar in size (705 Å
3), but different in
shape. Cholesterol, 7-dehydrocholesterol, and cholesterol
sulfate were identified as RORα agonists [Kallen et al.,
2004; Kallen et al., 2002].They were found to bind RORα
in a reversible manner and to enhance RORE-dependent
transcriptional activation by RORα in cells maintained in
cholesterol-depleted medium. On this basis, it has been
suggested that RORα might function as a lipid sensor
and be implicated in the regulation of lipid metabolism.
The latter would be consistent with reports indicating that
RORα regulates the expression of several genes involved
in lipid metabolism [Boukhtouche et al., 2004; Jakel et
al., 2006; Kallen et al., 2002; Kang et al., 2007; Lau et
al., 2008; Lau et al., 2004; Lind et al., 2005; Mamontova
et al., 1998;Wada et al., 2008a]. However, whether
cholesterol and cholesterol sulfate metabolites function
as genuine physiological agonists of RORα, and whether
other structurally-related lipids serve as endogenous
ligands of RORα, needs to be established.
X-ray structure analysis of the RORβ(LBD) identified
stearic acid as a fortuitously-captured ligand that
appeared to act as a stabilizer by filling the ligand-binding
pocket, rather than as a functional ligand [Stehlin et al.,
2001]. Subsequently, several retinoids, including all-trans
retinoic acid (ATRA) and the synthetic retinoid ALRT 1550
(ALRT), were identified as functional ligands for RORβ
[Stehlin-Gaon et al., 2003]. ATRA and ALRT 1550 were
able to bind RORβ(LBD) reversibly and with high affinity
and reduced RORβ-mediated transcriptional activation,
suggesting that they act as partial antagonists.These
retinoids were also able to bind RORγ and inhibit
RORγ-mediated transactivation, but did not bind RORα
or affect RORα-induced transactivation [Stehlin-Gaon et
al., 2003]. Interestingly, repression of RORβ-mediated
transcription was observed only in neuronal cells and not
in other cell types tested, indicating that this antagonism
may be rather cell type-dependent and involve an
interaction with (a) neuronal cell-specific RORβ
repressor(s) [Stehlin-Gaon et al., 2003]. Future studies
have to determine whether ATRA acts as a genuine
physiological ligand of RORβ and RORγ and establish
the physiological significance of such an interaction in
neuronal and non-neuronal cells.
Although future research needs to determine whether in
vivo ROR activity is regulated by endogenous ligands,
these crystallographic and structural studies do support
the concept that ROR activity can be modulated by
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Review Physiological functions of RORsFigure 2.  Mechanism of action of RORs, physiological functions and roles in disease. RORs bind as a monomer to ROREs consisting of the
GGTCA consensus core motif preceded by a 6A/T rich region. REV-ERBs can compete with RORs for binding to ROREs. RORs interact with coactivators
or corepressors to positively or negatively regulate gene transcription. RORs are critical in the regulation of many physiological processes and may
have a role in several pathologies. Although evidence has been provided indicating that certain ligands can modulate ROR transcriptional activity,
whether ROR activity is modulated in vivo by endogenous ligands has yet to be determined. RORs might serve as potential novel targets for
chemotherapeutic strategies to intervene in various disease processes.
specific endogenous and/or synthetic (ant)agonists [Kallen
et al., 2004; Kallen et al., 2002; Stehlin-Gaon et al., 2003].
This conclusion is highly relevant to the emerging roles
of RORs in several pathologies, including inflammation,
various autoimmune diseases, obesity, and asthma, and
the promise that these receptors might serve as potential
targets for pharmacological intervention in these diseases
(Figure 2).
Interaction with coregulatory proteins
For many receptors, binding of a ligand functions as a
switch that induces a conformational change in the
receptor that involves a repositioning of H12 (AF2)
[Darimont et al., 1998; Glass and Rosenfeld, 2000;
Harding et al., 1997; Heery et al., 2001; Heery et al.,
1997; McInerney et al., 1998; Nagy et al., 1999; Nolte et
al., 1998; Xu et al., 1999].When RORs are in a
www.nursa.org  NRS  | 2009 |  Vol. 7 |  DOI: 10.1621/nrs.07003 | Page 4 of 32
Review Physiological functions of RORstranscriptionally-active conformation, H12 with H3 and
H4 form a hydrophobic cleft and a charge clamp that
involves the participation of a conserved Lys in H3 and
a conserved Glu in H12 within RORs [Kallen et al., 2002;
Stehlin-Gaon et al., 2003; Stehlin et al., 2001].The clamp
serves as an interaction interface for LXXLL motifs
present in coactivators and related motifs in corepressors
[Gold et al., 2003; Harris et al., 2002; Kurebayashi et al.,
2004; Littman et al., 1999; Moraitis et al., 2002; Xie et al.,
2005]. Receptor:coactivator complexes, through their
histone acetylase activity, induce histone acetylation that
results in decompaction of chromatin and increased
transcription of target genes [Glass and Rosenfeld, 2000;
McKenna and O'Malley, 2002;Wolf et al., 2008; Xu,
2005], while receptor association with corepressor
complexes leads to histone deacetylation and
subsequently compaction of chromatin and repression of
gene expression [Horlein et al., 1995; Hu and Lazar,
2000; Nagy et al., 1999].
RORs interact with corepressors, as well as coactivators,
suggesting that they can function both as repressors and
activators of gene transcription.The coactivators NCOA1
(SRC1), NCOA2 (TIF2 or GRIP1), PGC-1α, p300, and
CBP [Atkins et al., 1999; Gold et al., 2003; Harding et al.,
1997; Harris et al., 2002; Jetten, 2004; Jetten and Joo,
2006; Kurebayashi et al., 2004; Lau et al., 1999; Lau et
al., 2004; Littman et al., 1999; Liu et al., 2007b; Xie et al.,
2005] and corepressors NCOR1, NCOR2, RIP140, and
the neuronal interacting factor X (NIX1) [Greiner et al.,
2000; Harding et al., 1997; Jetten, 2004; Jetten and Joo,
2006; Johnson et al., 2004; Littman et al., 1999] are
among the coregulators found within ROR protein
complexes. Recently, repression of ROR-mediated
transcriptional activation by the forkhead box transcription
factor p3 (FOXP3) was shown to depend on a direct
interaction between RORs and FOXP3 [Du et al., 2008;
Yang et al., 2008c; Zhou et al., 2008].
Posttranslational modifications
Posttranslational modifications, including phosphorylation,
acetylation, ubiquitination and sumoylation, play an
important role in regulating nuclear receptor activity and
stability [Faus and Haendler, 2006; Popov et al., 2007].
The ubiquitin (Ub)-proteasome system is intimately
involved in chromatin structure remodeling and
transcriptional control by nuclear receptors [Dace et al.,
2000; Dennis et al., 2001; Ismail and Nawaz, 2005;
Kinyamu et al., 2005; Poukka et al., 1999;Wallace and
Cidlowski, 2001]. Proteasome-mediated ubiquitination is
also an integral part of the mechanism by which ROR
receptor signaling is controlled. Inhibition of the 26S
proteasome complex by the proteasome inhibitor MG-132
results in an accumulation of ubiquitinated RORα protein
and reduces the transcriptional activity of this receptor
[Moraitis and Giguere, 2003]. Similarly, the corepressor
Hairless (Hr) [Cachon-Gonzalez et al., 1994;Thompson
et al., 2006], which functions as an effective repressor of
ROR-mediated transcriptional activation, enhances RORα
protein stability by protecting it from proteasome-mediated
degradation [Moraitis and Giguere, 2003; Moraitis et al.,
2002]. Reports showing that various proteasome subunits,
including proteasome subunit β type 6 (PSMB6) and the
26S ATPase subunit PSMC5, are part of ROR protein
complexes, are consistent with a role of the proteasome
system in the regulation of ROR transcriptional activity
[Atkins et al., 1999; Jetten and Joo, 2006].The
ubiquitin-conjugating enzyme I (UBE2I or UBC9), which
catalyzes sumoylation, was also found to interact with
RORs.Whether UBE2I catalyzes ROR sumoylation and
alters ROR activity needs to be established.
Recent studies demonstrated that activation of protein
kinase C induces phosphorylation of RORα1 and inhibits
RORα1-mediated transcriptional activation [Duplus et al.,
2008], while calmodulin-dependent kinase IV (CaMKIV)
has been shown to enhance the transcriptional activity
of RORα by a mechanism that does not involve
phosphorylation of RORα by CaMKIV [Kane and Means,
2000]. Extracellular signal-regulated kinase-2 (ERK2) has
been reported to phosphorylate RORα4 in vitro at Thr
128
[Lechtken et al., 2007]. Future studies are needed to
determine the physiological significance of these different
kinases on ROR activity and function.
RORs and development
Critical role of RORα in cerebellar development
Although RORα is expressed in a variety of tissues,
including testis, kidney, adipose and liver, it is most highly
expressed in the brain, particularly in the cerebellum and
thalamus [Becker-Andre et al., 1993; Carlberg et al., 1994;
Dussault et al., 1998; Hamilton et al., 1996;
Matysiak-Scholze and Nehls, 1997; Nakagawa et al.,
1997; Nakagawa et al., 1998; Nakagawa and O'Leary,
2003;Vogel et al., 2000].The function of RORα in brain
development has not been extensively studied beyond
the cerebellum. A high level of RORα expression was
observed in the cerebellar Purkinje cells, while RORα is
not detected in the granule cell layer [Ino, 2004; Matsui
et al., 1995; Nakagawa et al., 1997; Sashihara et al.,
1996; Sotelo and Wassef, 1991]. During Purkinje cell
development, RORα expression is first observed at E12.5,
just after Purkinje cell precursors exit the mitotic cycle
and leave the ventricular zone to migrate along radial glia
to form a temporary cerebellar plate-like structure [Gold
et al., 2003; Gold et al., 2007; Goldowitz and Hamre,
1998; Jetten and Joo, 2006].
RORα null mice, generated by targeted disruption of the
RORα gene, display essentially an identical phenotype
as homozygous staggerer mice (RORα
sg/sg) [Dussault et
al., 1998; Hamilton et al., 1996; Herrup and Mullen, 1981;
Landis and Sidman, 1978; Sidman et al., 1962; Steinmayr
et al., 1998].This natural mutant strain carries a 6.4 kb
intragenic insertion causing deletion of the fifth exon,
encoding the beginning of the LBD, and a frameshift that
results in a premature stop codon [Gold et al., 2007;
Hamilton et al., 1996]. RORα-deficient mice exhibit
several abnormalities, including thin long bones,
suggesting a role for RORα in bone formation [Meyer et
al., 2000]. In addition, these mice display ataxia and
severe cerebellar atrophy, characterized by significantly
fewer Purkinje cells and a loss of cerebellar granule cells
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et al., 1998; Gold et al., 2007; Hamilton et al., 1996;
Herrup and Mullen, 1979; Herrup and Mullen, 1981;
Landis and Reese, 1977; Landis and Sidman, 1978;
Sidman et al., 1962; Steinmayr et al., 1998]. Although the
morphology of the cerebellar cortex in young
heterozygous (RORα
sg/+) mice appears normal, upon
aging, an accelerated loss of Purkinje and granule cells
was observed [Doulazmi et al., 1999; Hadj-Sahraoui et
al., 2001; Hadj-Sahraoui et al., 1997; Zanjani et al., 1992].
At E17.5 of development, the number of Purkinje cells
generated appears to be similar between WT and
RORα
sg/sg mice [Doulazmi et al., 2001;Vogel et al., 2000].
However, by PND5, the number of Purkinje cells is
dramatically reduced and cells appear disorganized.
Surviving RORα
sg/sg Purkinje cells contain stunted
dendritic arbors lacking distal spiny branchlets and are
deficient in their assembly of mature synapses with
granule cells, suggesting that dendritogenesis is impaired.
This is accompanied by a lack of parallel fiber (PF) input
and a persistence of multiple climbing fiber (CF)
innervations [Boukhtouche et al., 2006a; Janmaat et al.,
2009; Mariani, 1982; Mariani and Changeux, 1980].
Dysfunctional synapse formation between PF and
Purkinje cells is associated with a delayed shift from the
glutamate transporter Slc17a6 (VGluT2) into Slc17a7
(VGluT1) in PF terminals and to an altered distribution of
the glutamate receptors, Grm1 and Grm2, in Purkinje
cells [Janmaat et al., 2009]. Expression of RORα in
RORα
sg/sg Purkinje cells was shown to restore normal
dendritogenesis in organotypic cultures [Boukhtouche et
al., 2006a].These observations indicated that RORα
does not regulate the genesis of Purkinje cells, but rather
their maturation, particularly dendritic differentiation
(Figure 3).This concept was further supported by
observations showing that several genes down-regulated
in Purkinje cells of RORα
sg/sg mice encode proteins
involved in the maturation of Purkinje cells.These include
genes involved in signal-dependent calcium release, such
as the calmodulin inhibitor Pcp4, the IP3 receptor (Itpr1)
and its interacting partner Cals1, the calcium-transporting
ATPase Atp2a2, and major intracellular calcium buffer 1
(Calb1) [Gold et al., 2003; Gold et al., 2007; Hamilton et
al., 1996; Messer et al., 1990]. In addition, several genes
linked to the glutamatergic pathway were expressed at
reduced levels in RORα
sg/sg mice, including the glutamate
receptor Grm1, the glutamate transporter Slc1a6, and its
anchor Spnb3, encoding a brain-specific β-spectrin.
The promoter regulatory regions of several genes
down-regulated in RORα
sg/sg Purkinje cells, including
those of Pcp2, Pcp4, Itpr1, Shh, and Slc1a6, contain
ROREs that bind RORα [Gold et al., 2003; Gold et al.,
2007; Serinagaoglu et al., 2007]. Chromatin
immunoprecipitation (ChIP) analysis demonstrated that
RORα is associated with these ROREs in vivo, suggesting
that these genes are directly regulated by RORα.
Moreover, these studies revealed the identity of several
transcriptional mediators that are part of RORα
transcription activation complexes at these ROREs.
Interestingly, the composition of these RORα:coactivator
complexes associated with different promoters exhibited
a certain promoter specificity. For example, the RORα
transactivation complex associated with the Pcp2-RORE
contained TIP60 (Tat-interactive protein, 60 kD), and
SRC-1; the Slc1a6-RORE bound complex contained CBP,
TIP60, SRC-1, and GRIP-1; while the Pcp4-RORE
associated complex contained β-catenin, SRC-1, p300,
and TIP60 [Gold et al., 2003].These results suggest that
the sequence and the promoter context of the RORE play
a critical role in determining the composition of the
RORα:coactivator complex recruited to each promoter.
The development of Purkinje cells and granule cells is
mutually dependent. Positioning and morphological
differentiation of Purkinje cells depends on granule cells,
while proliferation of granule precursors requires factors
released by Purkinje cells [Goldowitz and Hamre, 1998;
Vogel et al., 2000]. At birth, the number of granule cells
is somewhat reduced, and this becomes more prominent
during the first weeks after birth. In adult RORα-deficient
mice, the granular layer is very thin and depleted of
granule cells [Doulazmi et al., 2001; Doulazmi et al., 1999;
Dussault et al., 1998; Gold et al., 2007; Hamilton et al.,
1996; Herrup and Mullen, 1979; Herrup and Mullen, 1981;
Landis and Reese, 1977; Landis and Sidman, 1978;
Sidman et al., 1962; Steinmayr et al., 1998;Yoon, 1972].
Studies using WT:staggerer chimeras indicated that the
depletion of cerebellar granule cells in RORα
sg/sg mice is
related to abnormalities inherent to RORα
sg/sg Purkinje
cells [Herrup and Mullen, 1979; Herrup and Mullen, 1981].
This is consistent with the high level of expression of
RORα in Purkinje cells and the lack of RORα in cerebellar
granule cells. Sonic hedgehog (Shh) released by Purkinje
cells plays a critical role in the regulation of the
proliferation of cerebellar granule cells [Dahmane and
Ruiz i Altaba, 1999; Gold et al., 2003; Kenney et al., 2003;
Wallace, 1999] (Figure 3). Interaction of Shh with Patched
(Ptch) receptors on cerebellar granule precursors results
in the activation of GLI Krüppel-like zinc finger proteins
and the subsequent transcriptional activation of N-MYC
and other cell cycle regulatory genes.The expression of
Shh in RORα
sg/sg Purkinje cells was found to be reduced
several fold, suggesting that the repression of Shh may
be a critical factor in the diminished proliferation of granule
precursors [Gold et al., 2003; Gold et al., 2007].This is
consistent with the observed repression of several Shh
target genes, including N-MYC, in the cerebellum of
RORα
sg/sg mice.This hypothesis is further supported by
experiments showing that Shh was able to enhance
proliferation of granule precursor cells in sections of
cerebellum from PND4 RORα
sg/sg mice and partially
prevented the reduction in granule cells [Boukhtouche et
al., 2006a].These observations indicate that the
down-regulation of Shh in RORα
sg/sg mice is an important
contributing factor in the development of cerebellar
hypoplasia in these mice and that RORα functions as a
positive regulator of Shh expression. ChIP analysis
indicated that RORα regulates Shh expression directly
through ROREs in the promoter regulatory region of the
Shh gene. Moreover, these studies identified β-catenin
and p300 as constituents of the RORα transactivation
complex associated with the RORE in Shh.The
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Purkinje cells. RORα becomes highly expressed in postmitotic Purkinje cells. It regulates their maturation, particularly dendritic differentiation.
Dendritogenesis and the expression of several genes, including Shh, Itpr1, Pcp4, Calb1, Pcp2, and Slc1a6, normally expressed in mature Purkinje
cells, are inhibited in RORα-deficient mice.The transcription of several of these genes is under direct control of RORα. Shh released by Purkinje cells
interacts with Patched (Ptch) receptors on granule cell precursors, leading to activation of GLI transcription factors and the subsequent induction of
proliferation-promoting genes. Reduced Shh expression in Purkinje cells from RORα-deficient mice is a major factor in the cerebellar atrophy observed
in these mice. Cerebellar granule cells and Purkinje cells mutually interact (e.g., glutamatergic synapses).
association of β-catenin with RORα transactivation
complexes suggests a link between Wnt and ROR
signaling, and is consistent with a reported role for Wnt
signaling in cerebellar development [Salinas et al., 1994;
Wang et al., 2001].
Link between RORα and spinocerebellar ataxia
type 1 (SCA1)
Comparison of gene expression profiles indicated a
possible link between RORα and spinocerebellar ataxia
type 1 (SCA1), an autosomal dominant inherited
neurodegenerative disorder that is characterized by
progressive loss of motor coordination, speech
impairment, and problems swallowing [Serra et al., 2006;
Zoghbi and Orr, 2000]. SCA1 is caused by aberrant
effects triggered by an expanded polyglutamine (polyQ)
tract within the protein ataxin 1 (ATXN1), resulting in
variable degrees of neurodegeneration, predominantly
in the cerebellum (due to loss of Purkinje cells),
brainstem, and spinal cord. Sca1[82Q] mutant mice, which
express an Atxn1 protein containing an 82 glutamine
repeat, develop severe ataxia and degeneration of
Purkinje cells [Burright et al., 1995]. A considerable
overlap was observed between genes repressed in the
cerebellum of Sca1[82Q] mice and genes found to be
regulated by RORα in Purkinje cells, suggesting a
possible connection between the two [Gold et al., 2003;
Serra et al., 2004]. Immunohistochemical analysis
indicated that the level of RORα was significantly reduced
in Purkinje cells from Sca1[82Q] mice [Serra et al., 2006].
This reduction was found to be, at least in part, due to a
decrease in RORα protein stability. In addition, it was
demonstrated that RORα and ATXN1 are part of the same
protein complex.This association was indirect and
mediated by a direct interaction of ATXN1 with the
coactivator TIP60, which has been show to be part of
several RORα-coactivator complexes in Purkinje cells
[Gold et al., 2003; Serra et al., 2004]. It was concluded
that decreased levels of RORα protein in SCA1 Purkinje
cells causes reduced expression of RORα-target genes
that are critical for Purkinje cell development and function,
and consequently is an important contributory factor in
the neurodegeneration observed in SCA1 [Serra et al.,
2006].
Physiological Function of RORβ in brain and
retina
RORβ exhibits a restricted pattern of expression that is
limited to certain regions of the brain and retina [Andre
et al., 1998a; Andre et al., 1998b; Azadi et al., 2002;
Nakagawa and O'Leary, 2003; Schaeren-Wiemers et al.,
1997]. During the period between E12.5 and PND5 of
mouse development, RORβ is expressed in the neocortex
and dorsal thalamus in a highly dynamic, spatiotemporal
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2003]. In adult brain, RORβ mRNA is most highly
expressed in the cerebral cortex, thalamus,
hypothalamus, suprachiasmatic nucleus (SCN), and the
pineal gland, while little expression was detected in the
cerebellum or hippocampus [Andre et al., 1998a; Andre
et al., 1998b; Schaeren-Wiemers et al., 1997; Sumi et
al., 2002]. RORβ is also expressed in the anterior
olfactory nucleus posterior and sensory cortices.These
observations suggested that RORβ is highly restricted to
several regions involved in the processing of sensory
information.
Study of RORβ null mice provided several clues about
the physiological function of RORβ. RORβ null mice
exhibit several motor defects, including a ‘duck-like’ gait
and an impairment in several neurological reflexes, e.g.,
hind paw clasping reflex [Andre et al., 1998a; Masana et
al., 2007]. RORβ null mice display several behavioral
changes, including increased exploratory activity and
reduced anxiety behavior, and olfactory deficits [Masana
et al., 2007]. In addition, RORβ
-/- mice show a delayed
onset of male fertility [Andre et al., 1998a].
The relatively high expression in the retina and the
development of retinal degeneration in RORβ
-/- mice
suggested an important regulatory function for RORβ in
this tissue [Andre et al., 1998a]. At E17.5 of mouse and
rat development, RORβ expression is detected in the
formative ganglion cell layer and the neuroblastic layer
[Andre et al., 1998a; Schaeren-Wiemers et al., 1997;
Srinivas et al., 2006]. By PND6, the neuroblastic layer
has split into the inner nuclear layer of interneurons and
the outer nuclear layer, where the photoreceptor cells,
rods and cones, reside. At PND16 and older, RORβ is
still expressed in all retinal layers, but most highly in the
outermost part of the outer nuclear layer. RORβ
-/- mice
exhibit several retinal developmental defects. At PND6,
cell loss was observed in the ganglion layer, while the
interneurons in the inner layer appeared in disarray.
Although an outer nuclear layer was formed, it was
significantly thinner than in WT retina, but maintained for
several weeks. Rods and cones photoreceptors in the
outer layer appeared disorganized and lacked outer and
inner segments.These observations suggested that
RORβ plays a key role in the maturation of
photoreceptors, particularly the formation of the outer
segments, the light sensing structures of cones and rods
that contain opsin and rhodopsin, respectively [Srinivas
et al., 2006].
In most mammals, color vision depends on the
photopigments, S and M opsin, which are synthesized
by distinct cone populations [Ebrey and Koutalos, 2001].
In WT mice, S opsin expression is observed at PND6,
and by PND13 is concentrated to the outer segments of
maturing cones; however, in RORβ
-/- mice, induction of
S opsin (Opn1sw) is significantly delayed. After PND23,
S opsin is detected at greatly reduced levels. Little
difference in the induction of M opsin (Opn1mw) and
thyroid hormone receptor TRβ2, which is essential for
Opn1mw expression, was observed between WT and
RORβ
-/- mice.The transcription factor CRX (cone-rod
homeobox factor), which is critical for both S and M opsin
gene expression, is normally expressed in rods and cones
[Srinivas et al., 2006].These data and histological studies
suggested that RORβ is not a requirement for the initiation
of differentiation of progenitors into photoreceptors, but
specifically regulates their maturation, as illustrated by
the reduced level of S opsin.
Study of the Opn1sw promoter provided further evidence
that RORβ is an important regulator of Opn1sw
expression.The proximal promoter region of Opn1sw
contains two putative ROREs that are able to bind RORβ.
Optimal activation of this promoter region was found to
require a synergy between RORβ and CRX [Srinivas et
al., 2006].The latter is consistent with the co-expression
of both transcription factors in the photoreceptor layer
during the period when Opn1sw expression is induced.
The activation of the Opn1sw promoter by RORβ was
mediated principally through interaction with the most
proximal RORE and, as expected, required both the DBD
and AF2 domains of RORβ. Analysis of a transgene
consisting of LacZ controlled by the Opn1sw proximal
promoter region in mice showed that its expression was
restricted to the photoreceptors with features of cones in
the outer nuclear layer, while mutations in the ROREs
totally abolished this expression.These observations
indicate that RORβ is required for the induction of S opsin
and support the conclusion that RORβ regulates Opn1sw
transcription in a direct manner through ROREs within
its proximal promoter region. In addition, they explain the
greatly diminished expression of Opn1sw observed in the
retina of RORβ
-/- mice.
Role for RORα in cone development
Recent studies have indicated that RORα also plays a
role in mouse retinal development [Fujieda et al., 2009;
Ino, 2004]. In the retina, RORα expression is highly
dynamic. It is first observed at E17 in the developing
ganglion layer, while it is not detectable in the neuroblastic
layer. At PND3, RORα was also found in the outer and
inner border of the neuroblastic layer. In retina of adult
mice, RORα is intensely expressed in the ganglion cell
layer, the inner nuclear layer, and in cone photoreceptors
in the outer layer, as indicated by its co-localization with
both S and M opsin. Analysis of Opn1sw and Opn1mw
expression showed that their level of expression was
significantly reduced in RORα
sg/sg retina. Expression of
cone arrestin (Arr3) was also diminished, whereas the
expression of several other cone genes, including
phosphodiesterases 6c and 6h (Pde6c and Pde6h) and
cyclic nucleotide gated channel b3 (Gngb3), and the
expression of the rod-specific gene rhodopsin (Rho) were
unchanged. Expression of RORβ was also unaffected in
RORα
sg/sg retina. As demonstrated for RORβ, RORα was
shown to act in synergy with CRX to induce Opn1sw
expression [Fujieda et al., 2009]. In vivo ChIP analysis
supported the conclusion that Opn1sw, Opn1mw, and
Arr3 are direct targets of RORα regulation.Thus, both
RORα and RORβ function as regulators of cone
development and Opn1sw; however, in contrast to RORα,
RORβ does not affect Opn1mw expression.These data
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functional redundancy, their functions in cone
development appear largely distinct from each other.
Role of RORγ in the development of secondary
lymphoid tissues
RORγ1 and RORγt (RORγ2) exhibit distinct patterns of
tissue-specific expression. RORγ1 is expressed in many
tissues, including liver, adipose, skeletal muscle, and
kidney, while the expression of RORγt is exclusively
expressed in a few distinct cell types of the immune
system [Eberl and Littman, 2003; Eberl and Littman, 2004;
Jetten, 2004; Jetten and Joo, 2006; Lipp and Muller,
2004]. Mice deficient in RORγ expression lack lymph
nodes and Peyer's patches (PPs), suggesting that RORγ
is indispensable for lymph node organogenesis and
development of PPs [Eberl and Littman, 2003; Eberl et
al., 2004; He, 2002; Jetten and Joo, 2006; Jetten et al.,
2001; Jetten and Ueda, 2002; Kurebayashi et al., 2000;
Lipp and Muller, 2004; Littman et al., 1999; Sun et al.,
2000]. Lymphoid tissue inducer (LTi) cells play a critical
role in the development of lymph nodes and PPs. LTi
cells originate from hematopoietic precursor cells in the
fetal liver and have been recently characterized as
CD45
intCD4
+CD3
-CD127(IL-7Rα)
+Lin
- cells in mice and
in humans as lineage-negative
CD45
intCD4
-CD3
-CD127
hiLin
- cells [Cupedo et al., 2009;
Eberl and Littman, 2003; Mebius et al., 2001; Mebius et
al., 1997]. LTi cells are recruited to the lymph node
anlagen through their interaction with mesenchymal
organizer cells, specialized cells derived from
differentiating mesenchymal cells [Cupedo et al., 2002;
Cupedo and Mebius, 2005; Eberl, 2005; Eberl and
Littman, 2003; Lipp and Muller, 2004] (Figure 4).This
cell:cell interaction involves several positive feedback
loops and amplifying mechanisms. Lymph node
organogenesis is initiated by interaction of lymphotoxin
α1β2 at the surface of LTi cells with their respective
receptors on mesenchymal organizer cells.This leads to
the induction of several adhesion molecules, including
vascular cell adhesion molecule 1 (VCAM-1) and mucosal
addressin cellular adhesion molecule 1 (MadCAM-1) and
the subsequent production of homeostatic chemokines
by mesenchymal organizer cells [Cupedo et al., 2002;
Cupedo and Mebius, 2005; Eberl, 2005; Lipp and Muller,
2004; Muller et al., 2003;Yoshida et al., 2002] (Figure
4). In addition to reinforcing the interaction between LTi
and mesenchymal organizer cells, these interactions
amplify the recruitment of additional LTi cells and promote
the recruitment of other cells, such as monocytes and T
and B lymphocytes, from the circulation [Cupedo and
Mebius, 2005; Muller et al., 2003]. Subsequent studies
showed that LTi cells are absent from spleen, mesentery,
and intestine of RORγ
-/- E18.5 embryos, indicating that
RORγt plays a critical role in the generation and/or
survival of LTi cells [Eberl, 2005; Eberl and Littman, 2003].
As a consequence, the lack of lymph nodes and PPs in
RORγt- or RORγ-deficient mice is due to the absence of
LTi cells.
Besides PPs and mesenteric lymph nodes, the intestinal
immune system contains several other lymphoid cell
compartments, including cryptopatches and isolated
lymphoid follicles (ILFs) [Eberl, 2005;Taylor and Williams,
2005] (Figure 4). ILFs develop from cryptopatches in
response to inflammatory innate immune signals
generated by the colonization of the intestine by bacteria.
Lin
-cKit
+CD127
+CD44
+ cells in cryptopatches and in ILFs
express high levels of RORγt and appear to constitute
the adult counterpart of LTi cells [Eberl, 2005; Eberl and
Littman, 2004].The deficiency in cryptopatches and ILFs
observed in RORγ
-/- mice indicate that RORγt is essential
for the development of these cell compartments and is
due to the absence of these LTi-like cells in these mice.
Recent studies identified a novel lymphocyte population
in the intestinal lamina propria that produces IL-22 and
co-expresses RORγt and CD127, and natural killer (NK)
cell markers NKp46 and NK1.1
(CD3
-RORγt
hiCD127
+NKp46
+NK1.1
int) [Cupedo et al.,
2009; Luci et al., 2009; Sanos et al., 2009] (Figure 4).
These cells are absent in RORγt-deficient mice. Because
of its dependence on RORγt and its CD127
+c-Kit
+
phenotype, these NK cells resemble LTi cells, suggesting
a possible link between the two cell types. LTi cells have
been reported to be able to differentiate into NK and
antigen presenting cells [Mebius et al., 2001; Mebius et
al., 1997].The basic helix-loop-helix transcription factor
Id2, which as RORγt is expressed in LTi cells, is essential
for both LTi and NK cell development [Yokota et al.,
1999]. In contrast, peripheral NK cells do not express
RORγt and their number is unaffected in RORγ-deficient
mice [Sun et al., 2000]. It is has been suggested that
RORγt
hiNKp46
+NK1.1
int cells do not belong to the NK cell
lineage, but may be derived from the
Lin
-Kit
+CD127
+RORγt
hi LTi-like cells in cryptopatches
[Cupedo et al., 2009; Luci et al., 2009; Sanos et al., 2009].
The precise role of these cells in normal intestinal mucosa
immunity and pathology, including colitis, needs further
study.
In contrast to lymph nodes and Peyer’s patches, the
development of several other lymphoid tissues, including
nasal- and bronchial-associated lymphoid tissue (BALT
and NALT), was undisturbed in RORγ
-/- mice, suggesting
that the organogenesis of these lymphoid tissues involves
a different mechanism [Harmsen et al., 2002].
Critical functions of RORγ in thymopoiesis
Several studies have demonstrated that RORγt plays a
critical role in the regulation of thymopoiesis [Guo et al.,
2002; He, 2000; He et al., 1998; Hirose et al., 1994;
Jetten, 2004; Jetten and Joo, 2006; Kurebayashi et al.,
2000; Medvedev et al., 1996; Ortiz et al., 1995; Sun et
al., 2000]. During thymopoiesis, T cell precursor
CD25
-CD44
+CD4
-CD8
- cells (DN1) differentiate
successively via two intermediate stages, CD25
+CD44
+
(DN2) and CD25
+CD44
- (DN3), into CD44
-CD25
- (DN4)
thymocytes (Figure 5).These cells then differentiate via
immature single positive (ISP) cells (CD3
-CD4
-CD8
low)
into double positive CD4
+CD8
+ (DP) thymocytes
[Miyazaki, 1997]. After successful T cell receptor α
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Review Physiological functions of RORsFigure 4.  RORγt is essential for the development of secondary lymphoid tissues. Lymphoid tissue inducer (LTi) cells are derived from fetal
liver hematopoietic stem cells.This differentiation is accompanied by induction of the transcription factors Id2 and RORγt. LTi cells are recruited from
the circulation by mesenchymal organizer cells.This is mediated by multiple receptor-ligand interactions. LTi cells are required for the development of
lymph nodes, Peyer’s patches, cryptopatches, and isolated lymphoid follicles (ILFs), which are thought to be derived from cryptopatches after the
colonization of the intestine by bacteria. Recently, a novel lymphocyte population (NKp46
+NK1.1
intCD127
+RORγt
hi) was identified in the gut that may
be derived from LTi-like cells in cryptopatches. RORγt is required for the generation and/or survival of LTi cells.The absence of LTi cells in RORγ-deficient
mice is responsible for the lack of lymph nodes, Peyer’s patches, cryptopatches, ILFs, and NKp46
+NK1.1
intCD127
+RORγt
hi cells.
(TCRα) gene rearrangement, DP cells expressing TCRαβ
receptor undergo a careful selection process to eliminate
thymocytes expressing nonfunctional or autoreactive TCR
[Starr et al., 2003; Zhang et al., 2005].The positive
selected DP thymocytes mature into single positive (SP)
CD4
+CD8
- helper and CD4
-CD8
+ cytotoxic T cells that
then colonize the secondary lymphoid organs, including
the spleen, lymph nodes, and PPs.
RORγt is transiently expressed during thymopoiesis [Guo
et al., 2002; He, 2002; He et al., 2000; He et al., 1998;
Jetten, 2004; Jetten and Joo, 2006; Jetten et al., 2001;
Sun et al., 2000] (Figure 5). It is undetectable in DN
thymocytes and highly induced when ISP cells
differentiate into DP thymocytes and again
down-regulated when DP thymocytes differentiate into
mature T lymphocytes. At birth and during early stages
of life, RORγ null mice have a significantly smaller thymus
compared to wild type mice as a result of a drastic
reduction in the number of double positive DP and SP
thymocytes, while the percentage of ISP thymocytes is
greatly increased [Eberl and Littman, 2003; Jetten et al.,
2001; Jetten and Ueda, 2002; Kurebayashi et al., 2000;
Sun et al., 2000].The accumulation of ISP cells in RORγ
-/-
mice appears to be due to a delay in the differentiation
of ISP into DP cells, suggesting a role for RORγt in the
regulation of the ISP-DP transition [Guo et al., 2002]. In
addition, DP thymocytes undergo massive apoptosis in
vivo and in vitro [Jetten, 2004; Jetten and Joo, 2006;
Jetten et al., 2001; Kurebayashi et al., 2000; Sun et al.,
2000].The accelerated apoptosis of RORγ
-/- DP
thymocytes is related to reduced expression of the
anti-apoptotic gene Bcl-XL.This repression is an early
and key event in accelerated apoptosis in RORγ
-/-
thymocytes [Sun et al., 2000; Xie et al., 2005].Thus,
RORγ functions as a positive regulator of Bcl-XL
expression and, as a result, promotes the survival of DP
thymocytes, thereby enabling gene rearrangement [Eberl
et al., 2004; He et al., 1998; Jetten, 2004; Jetten and Joo,
2006; Jetten et al., 2001; Jetten and Ueda, 2002;
Kurebayashi et al., 2000; Ma et al., 1995].
Little is still understood about the mechanism by which
Bcl-XL and RORγt expression are regulated during
thymopoiesis.The reduced expression of Bcl-XL in RORγ
-/-
mice and the observation that the induction and
down-regulation of Bcl-XL and RORγt expression occur
in parallel, are consistent with the concept that RORγt
regulates Bcl-XL expression.Whether this regulation
involves a direct or indirect mechanism has yet to be
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Review Physiological functions of RORsFigure 5.  Role of RORγt in thymopoiesis. CD4
-CD8
-CD25
-CD44
+ (DN1) cells differentiate via DN2, DN3, DN4 into immature single positive (ISP)
cells (CD3
-CD4
-CD8
low).These cells subsequently differentiate into CD3
+CD4
+CD8
+, DP thymocytes. RORγt, as well as Bcl-XL, are induced during the
ISP-DP transition and again down-regulated during the differentiation of DP into CD4
+ and CD8
+ single positive cells. RORγt promotes the differentiation
of ISP into DP cells and positively regulates the expression of the anti-apoptotic gene Bcl-XL.The latter enhances cell survival that subsequently
promotes TCR rearrangements. Lack of RORγt expression inhibits the ISP-DP transition and reduces expression of Bcl-XL in DP thymocytes.The
latter results in accelerated apoptosis, reduced lifespan of DP thymocytes and, consequently, impaired TCRα rearrangements
established. A recent study provided evidence for a link
between early growth response gene 3 (EGR3)
expression and the regulation of RORγt and Bcl-XL [Xi
and Kersh, 2004; Xi et al., 2006]. Pre-TCR signals
transiently induce EGR3, which promotes proliferation,
whereas the subsequent down-regulation of EGR3 leads
to growth cessation and induction of RORγt and Bcl-XL
needed for cell survival and proper gene rearrangement.
Analysis of gene expression profiles of thymocytes from
WT and RORγ
-/- mice identified additional changes in
gene expression, including repression of the transcription
factor EGR1, Ngfi-A binding protein 2 (NAB2), and the
glucocorticoid-induced transcript 1 (GLCCI1) [Kang et
al., 2006]. One of the genes most dramatically repressed
in thymocytes from RORγ
-/- mice is
oligonucleotide/oligosaccharide-binding fold-containing
2a (Obfc2a, also named NABP1).The pattern of Obfc2a
expression during thymopoiesis correlates with that of
RORγt.Therefore, Obfc2a might be a potential RORγ
target gene; alternatively, its down-regulation is just a
consequence of the reduction in DP cells observed in
RORγ
-/- mice. In summary, these studies indicate that
RORγ plays a critical role in thymocyte homeostasis by
regulating differentiation, proliferation, and apoptosis of
thymocytes [He, 2002; Jetten, 2004; Jetten and Joo,
2006; Jetten et al., 2001;Winoto and Littman, 2002].
Role of RORα in lymphocyte development
Both the spleen and the thymus are significantly smaller
in RORα-deficient mice, suggesting that RORα may have
a role in the regulation of thymopoiesis and lymphocyte
development [Dzhagalov et al., 2004;Trenkner and
Hoffmann, 1986]. RORα mRNA is expressed at low levels
in DP thymocytes and at high levels in SP thymocytes,
while it is decreased in mature CD8
+ and increased in
mature CD4
+ T lymphocytes. B220
+ B lymphocytes
express low levels of RORα.The total number of
thymocytes and splenocytes is greatly diminished in
RORα
-/- mice and is associated with a loss of DP
thymocytes and a corresponding increase in the
percentage of DN and SP thymocytes [Dzhagalov et al.,
2004]. In RORα
-/- spleen, both mature T and B
lymphocytes were significantly reduced, suggesting that
RORα plays a critical role in lymphocyte development.
No differences were observed between RORα
-/- and WT
mice in the induction of CD4
+ and CD8
+ T lymphocyte
proliferation in response to anti-CD3 or lipopolysaccharide
(LPS), nor in the induction of cytokines by TNFα
[Dzhagalov et al., 2004]. In contrast, the induction of IL-6
and tumor necrosis factor α was greatly increased in
RORα
-/- mast cells and macrophages after LPS treatment
[Dzhagalov et al., 2004; Kopmels et al., 1992].These
results indicate that at least in certain immune cells,
RORα functions as a negative regulator of cytokine
expression. Although the mechanism of this repression
is not fully understood, RORα has been reported to
positively regulate the expression of IKBα, a negative
regulator of the NF-κB signaling pathway [Delerive et al.,
2001]. On this basis, it was concluded that RORα might
function as a negative regulator of inflammation.
RORs and T cell lineage specification
Role of RORs in Th17 cell differentiation
Recent studies identified a critical role for RORs in the
regulation of lineage specification in helper T cells [Chen
et al., 2007; Chen and O'Shea, 2008; Dong, 2008;
Furuzawa-Carballeda et al., 2007; Huang et al., 2007;
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O'Shea, 2007;Weaver et al., 2007;Yang et al., 2008d].
Differentiation into different effector CD4
+T cell lineages,
T helper (Th) 1, Th2, Th17, and T regulatory (Treg or Th3)
cells is initiated through an interaction of dendritic cells
with uncommitted (naïve) CD4
+T helper cells (Thp).Th1,
Th2, Treg, and Th17 are characterized by their synthesis
of specific cytokines and their immuno-regulatory
functions (Figure 6). Interferon γ is the signature cytokine
produced by Th1 cells, while IL-4, IL-5 and IL-13 are
major cytokines produced by Th2 cells.The recently
discovered Th17 cells produce IL-17A (IL-17), IL-17F,
IL-21, and IL-22 as major cytokines, while Treg cells
synthesize IL-10 and TGFβ1 [Bettelli et al., 2008; Chen
and O'Shea, 2008; Dong, 2008; Harrington et al., 2006;
Park et al., 2005].T helper and Treg cells play a critical
role in several inflammatory responses, including adaptive
immune responses to various pathogens. Host defense
is coordinated by the proinflammatory Th1, Th2, and Th17
cells, while Treg cells are involved in the down regulation
and contraction of an immune inflammatory response.
Th17 cells are believed to be the major proinflammatory
cells involved in autoimmunity, while Treg cells protect
against autoimmunity [Dong, 2008; Furuzawa-Carballeda
et al., 2007; Ivanov et al., 2007; Laurence and O'Shea,
2007;Weaver et al., 2007]. Differentiation along different
lineages is initiated by dendritic cells, which process and
present (microbial) antigens to TCRs on Thp cells.
Interaction of dendritic cells with different classes of
pathogens results in the activation of different pathways
and the release of different cytokines that subsequently
interact with receptors on Thp cells and either guide or
repress their differentiation along different lineages
(Figure 6).The latter involves the activation of distinct
signaling cascades and transcription factors and the
synthesis of other cyto/chemokines and cyto/chemokine
receptors that are part of additional positive and negative
feedback loops. For example, induction of Th1 cells by
IL-12 involves the transcription factors STAT4, STAT1,
and T-bet, while differentiation along the Th2 lineage in
response to IL-4 requires STAT6 and GATA3 [Harrington
et al., 2006; Moulton and Farber, 2006]. Differentiation
into Treg cells and Th17 cells is often reciprocal, involving
several positive and negative regulatory networks that
favor one or the other lineage [Bettelli et al., 2006; Bettelli
et al., 2008; Dong, 2008; Furuzawa-Carballeda et al.,
2007; Harrington et al., 2006; Ivanov et al., 2006; Ivanov
et al., 2007; Laurence and O'Shea, 2007; Park et al.,
2005;Veldhoen et al., 2006;Weaver et al., 2007].This
includes a yin-yang relationship between RORγt and
FOXP3 expression and their regulation by several
cytokines, transforming growth factor β (TGFβ), and
ATRA.
Littman, Cua, and their colleagues were first to report that
RORγt is required for the differentiation of naïve CD4
+ T
cells into Th17 cells [Ivanov et al., 2006; Ivanov et al.,
2007; Manel et al., 2008].This was supported by findings
from several other laboratories [Dong, 2008; Laurence
et al., 2007;Yang et al., 2007b;Yang et al., 2008d].
RORγt is induced during differentiation of
antigen-stimulated Thp cells along the Th17 lineage in
response to IL-6 or IL-21 and TGFβ (Figure 7). Cells
deficient in IL-6 do neither express RORγt nor IL-17F and
IL23R [Korn et al., 2007a; Laurence et al., 2007;Yang et
al., 2007b]. IL-6 mediates its action through activation of
STAT3. Deficiency in STAT3 greatly impaired the
activation of RORγt expression and Th17 differentiation,
suggesting that this induction is STAT3-dependent [Harris
et al., 2007; Nurieva et al., 2007;Yang et al., 2007b].
Inversely, deficiency in suppressor of cytokine signaling
3 (SOCS3), a negative regulator of STAT3 activity,
enhances Th17 differentiation [Chen et al., 2006].
Whether STAT3 regulates RORγt expression directly by
binding to the RORγt promoter needs to be established.
Additional evidence for a role of RORγt in Th17
differentiation came from studies showing that Thp cells
isolated from RORγ null mice exhibited a marked
reduction in their ability to undergo differentiation along
the Th17 lineage [Ivanov et al., 2006; Nurieva et al., 2007;
Yang et al., 2007b]. Conversely, exogenous expression
of RORγt in Thp cells greatly increased the expression
of IL-17 cytokines and IL23R in the absence of cytokines.
Subsequent studies showed that, like RORγt, RORα is
highly induced during Th17 cell differentiation in a
STAT3-dependent manner [Yang et al., 2008d] (Figure
7). Deficiency in RORα reduced IL-17 and IL23R, but not
IL-17F or IL-22 expression, while exogenous expression
of RORα in Thp cells or Jurkat cells enhanced IL-17,
IL-17F, IL-22, and IL23R expression [Du et al., 2008;
Yang et al., 2008d].These observations indicate that
RORα also functions as a positive regulator of Th17
differentiation, suggesting a degree of functional
redundancy between RORγt and RORα.This was
consistent with findings showing that Th17 differentiation
was completely impaired in Thp cells deficient in both
RORα and RORγ [Yang et al., 2008c;Yang et al., 2008d].
Thus, both RORα and RORγt are required for optimal
differentiation of Thp cells into Th17 cells; however,
RORγt appears to be the major player in this process
because RORγt deficiency has a more pronounced effect
on the expression of Th17 cytokines than loss of RORα.
Whether RORα and RORγ have any unique roles in the
regulation of gene expression during or after Th17
differentiation needs further study.
In addition to the induction of RORγt, IL-17, and IL-17F,
differentiation along the Th17 lineage is associated with
increased expression of IL-21 and IL23R
[Acosta-Rodriguez et al., 2007; Korn et al., 2007a;
Laurence and O'Shea, 2007; Nurieva et al., 2007;Wilson
et al., 2007; Zhou et al., 2007].The induction of IL-21 in
response to IL-6 involves direct binding of STAT3 to the
IL-21 promoter. IL-21, through its activation of STAT3,
synergizes with IL-6 and TGFβ to induce RORγt and IL-17
expression [Nurieva et al., 2007; Palmer and Weaver,
2007; Zhou et al., 2007] (Figure 7). IL-21 expression is
not affected in RORγ-deficient mice, suggesting that this
regulation occurs upstream of RORγ. IL-21 is also
expressed in T follicular helper T (Tfh) cells, another novel
T cell subset that develops independent of RORs [Nurieva
et al., 2008]. In contrast to IL-21, the induction of IL23R
is greatly reduced in RORγ-deficient mice, suggesting
that its expression is regulated by RORγt. IL23R itself is
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+ T cell lineages, T helper (Th) 1, Th2,
Th17, and T regulatory (Treg) cells is initiated through an interaction of dendritic cells with uncommitted (naïve) CD4
+ T helper cells (Thp).The effector
cell types are characterized by their synthesis of specific cytokines and their immuno-regulatory functions, as indicated on the right.The differentiation
along different lineages involves different cytokines and the activation of distinct signaling cascades and transcription factors that result in the induction
of additional cyto/chemokines and cyto/chemokine receptors, which may be part of positive and negative feedback loops.These cytokines and
transcription factors may favor one cell lineage, while inhibiting another (not indicated). RORα and RORγt are induced during differentiation of Thp into
the Th17 lineage and are critical for this lineage specification.
part of a positive feedback loop; it allows IL-23 to bind,
thereby reinforcing Th17 differentiation through activation
of STAT3 [Ivanov et al., 2007; McGeachy et al., 2007;
Yang et al., 2007b; Zhou et al., 2007].
Suppression of ROR transcriptional activity by
FOXP3
Treg and Th17 cells are reciprocally regulated, involving
several positive and negative regulatory networks [Bettelli
et al., 2008; Dong, 2008; Furuzawa-Carballeda et al.,
2007; Ivanov et al., 2007; Laurence and O'Shea, 2007;
Nurieva et al., 2007;Weaver et al., 2007; Zheng and
Rudensky, 2007; Zhou et al., 2008].The balance between
the expression of RORγt and the forkhead box
transcription factor p3 (FOXP3) plays a critical role in
determining whether uncommitted CD4
+ T helper cells
differentiate into Treg or Th17 cells (Figure 6). FOXP3
contains a repressor domain in the N-terminal half and a
C2H2 zinc finger, a leucine zipper, and a forkhead domain
at its C-terminal half, allowing the protein to function as
an activator or repressor of gene transcription [Campbell
and Ziegler, 2007; Carson et al., 2006; Li et al., 2007;
Lopes et al., 2006]. FOXP3 is predominantly expressed
in CD4
+CD25
+Treg cells, where it plays an important role
in directing differentiation [Campbell and Ziegler, 2007;
Lochner et al., 2008; Zheng and Rudensky, 2007]. In
addition, it regulates several functional properties and
contributes to the survival of Treg cells. FOXP3-deficient
mice lack Treg cells and are highly susceptible to
inflammatory disease [Brunkow et al., 2001; Fontenot et
al., 2005]. Conversely, induction or exogenous expression
of FOXP3 inhibits Th17 differentiation.
Regulation of FOXP3 expression by TGFβ and IL-6 plays
a critical role in Treg and Th17 lineage determination
[Bettelli et al., 2008; Chen et al., 2007; Dong, 2008;
Ivanov et al., 2007;Weaver et al., 2007]. In the presence
of TCR engagement, TGFβ induces FOXP3 expression
and Treg differentiation in murine Thp cells. Although
TGFβ can moderately enhance the expression of RORα
and RORγt, FOXP3 is induced at much higher levels,
thereby shifting the ROR/FOXP3 balance towards FOXP3
and Treg differentiation [Bettelli et al., 2006; Chen et al.,
2003; Fantini et al., 2004; Korn et al., 2007a; Nurieva et
al., 2007;Veldhoen et al., 2006;Wan and Flavell, 2007;
Yang et al., 2008a; Zhou et al., 2008] (Figure 7). Addition
of IL-6 or IL-21 inhibits the induction of FOXP3 by TGFβ
and activates RORα and RORγt expression, thereby
shifting the ROR/FOXP3 balance in favor of Th17
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Review Physiological functions of RORsFigure 7.  RORs are essential for Th17 cell differentiation and IL-17 expression. In the presence of TCR engagement, treatment of Thp cells
with IL-6 plus TGFβ1 induces differentiation along the Th17 lineage and the activation of several genes, including IL-21, RORα, RORγt, IL-17, IL-17F,
IL-22, and IL23R. Interaction of IL-23 and IL-21 with, respectively, IL23R and IL21R, reinforce Th17 differentiation and ROR expression. RORα and
RORγt are required for the induction of IL-17, IL-17F, and IL23R, but not IL-21. A balance between FOXP3, which is induced by treatment with TGFβ
alone, determines whether Thp cells differentiate into Th17 or Treg cells. ATRA, through activation of RARα-RXR complexes, leads to increased FOXP3
and reduced ROR expression. FOXP3 inhibits RORα and RORγt transcriptional activity by interacting directly with RORs, thereby promoting differentiation
along the Treg lineage and inhibiting Th17 differentiation.Transcriptional regulators IRF4 and RUNX1 have also been implicated in the regulation of
Treg and Th17 differentiation.
differentiation.These observations indicate that FOXP3
represses Th17 differentiation by antagonizing RORγt
function rather than inhibiting its expression [Du et al.,
2008; Ichiyama et al., 2008; Ivanov et al., 2007;Yang et
al., 2008c; Zhou et al., 2008].This antagonism is
mediated through a direct interaction of FOXP3 with
RORα and RORγt and involves the AF2 domain of RORs
and an LXXLL motif within a region encoded by exon 2
of FOXP3. Mutation of this motif greatly inhibits the
interaction of FOXP3 with RORs, but did not completely
prevent FOXP3-mediated suppression of ROR activity.
Transcriptional repression by FOXP3 involves an
interaction with the histone acetyltransferase TIP60 and
histone deacetylase HDAC7 through the 106-190 amino
acid region of FOXP3 [Li et al., 2007]. Deletion of this
region diminishes the inhibitory effect of FOXP3 on
ROR-mediated transactivation, while lack of both the
LXXLL motif and the TIP60-HDAC7 interaction domain
totally abolished the FOXP3-mediated repression [Yang
et al., 2008c].Thus, the interaction of FOXP3, possibly
in complex with TIP60 and HDAC, with RORs represses
ROR transcriptional activity and consequently inhibits the
activation of IL-17 expression and Th17 differentiation by
RORα and RORγt.
A number of other cytokines and transcription factors
influence the balance between Treg and Th17
differentiation. In contrast to IL-6, IL-21, and IL23, IL-2
inhibits RORγt expression and Th17 differentiation through
a STAT5-dependent mechanism and promotes the
generation of Treg cells [Ivanov et al., 2007; Laurence et
al., 2007]. IL-10, in addition to inhibiting Th1
differentiation, also suppresses Th17 differentiation and
the expression of RORγt and IL-17 [Gu et al., 2008].
Conversely, RORγt expression and Th17 differentiation
is enhanced in IL-10
-/- spleen cells. Moreover, treatment
of IL-10
-/- macrophages with LPS greatly induces RORγt
and IL-17 expression.The increased expression of RORγ
and IL-17 in IL-10
-/- spleen cells and LPS-treated
macrophages was repressed by the addition of IL-10. In
addition to the STAT transcription factors, interferon
regulatory factor 4 (IRF4) has been reported to regulate
T lineage commitment and to be required for Th17
differentiation [Brustle et al., 2007; Huber et al., 2008].
IRF4 is essential for IL21-induced Th17 differentiation.
The expression of RORα, RORγt, and IL-17 are
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the expression of FOXP3 is increased, indicating that
IRF4 also plays a role in regulating the balance between
Th17 and Treg cells.Thus, the balance between Th17
and Treg differentiation is under a complex control,
involving multiple transcription factors.
Suppression of Th17 differentiation and RORγt
expression by ATRA
Retinoids play an important role in the control of several
immune functions, including the commitment of Thp cells
to different lineages [Iwata et al., 2003; Iwata et al., 2004].
ATRA produced from retinol by dendritic cells has been
demonstrated to negatively regulate Th1 and Th2 cell
differentiation [Iwata et al., 2003]. More recent studies
showed that retinoic acid is a critical factor in controlling
the balance between Th17 and Treg cells [Coombes et
al., 2007; Mucida et al., 2007; Sun et al., 2007]. Upon
TCR activation, the differentiation of Thp cells into Treg
cells was shown to depend on both TGFβ and ATRA
[Benson et al., 2007; Coombes et al., 2007; Elias et al.,
2008; Sun et al., 2007]. ATRA inhibited the induction of
Th17 differentiation and down-regulated RORγt
expression in response to TGFβ and IL-6, and instead
promoted FOXP3 expression and the subsequent
generation of Treg cells (Figure 7). In addition to IL-17,
ATRA also represses the expression of IL-23R and
IL-6Rα.These findings are consistent with the concept
that differentiation of TCR-activated Thp cells into Th17
or Treg is decided by the balance between FOXP3 and
RORγt.
The precise mechanism of the inhibition of RORγt and
induction of FOXP3 expression by ATRA still needs to
be elucidated. Because IL-2 induces FOXP3 expression
through the activation of STAT5, ATRA could enhance
FOXP3 through increased IL-2 expression and STAT5
activation. However, FOXP3 induction by ATRA was
found to be independent of IL-2 and STAT5 [Elias et al.,
2008]. Binding to and activation of retinoic acid receptors
α, β, and γ (RARs), in a heterodimeric complex with
RXRs, is the major mechanism by which ATRA regulates
gene transcription [Minucci and Ozato, 1996].The retinoid
(4-[E-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]
benzoic acid (TTNPB), a synthetic RAR pan-agonist,
effectively induced FOXP3 expression and Treg
differentiation, while an RAR-antagonist inhibited this
induction by ATRA.These observations suggested that
these effects of ATRA are mediated by RARs. Study of
RAR-selective retinoids showed that RARα rather than
RARγ was found to be the key player in the induction of
FOXP3 and suppression of Th17 differentiation [Elias et
al., 2008].This was supported by data demonstrating that
ATRA was able to promote the conversion of RARβ- and
RARγ-deficient Thp cells into FOXP3
+ cells, but not in
Thp cells isolated from RARα-deficient mice [Hill et al.,
2008]. It has been suggested that stimulation of the TGFβ
signaling pathway might partly explain the increased Treg
differentiation by ATRA in the presence of TGFβ.This is
supported by findings showing that ATRA increases the
expression and phosphorylation of SMAD3 [Xiao et al.,
2008]. However, recent studies indicated that the
induction of Treg cells by ATRA is mediated by an indirect
mechanism involving alleviation of the inhibition of FOXP3
expression by CD4
+CD44
hi memory cells [Hill et al., 2008].
The inhibition of Th17 differentiation by ATRA might
explain the protective effects of retinoids in animal models
of autoimmune disease [Wang et al., 2000; Xiao et al.,
2008]. Supplementation with ATRA suppresses the
development of experimental autoimmune
encephalomyelitis (EAE) in mice by inhibiting
proinflammatory responses.This suppression appears
to be related to the inhibition of Th17 cell generation
rather than to an increase in Treg cells.
Regulation of IL-17 by RORs
Although the expression of IL-17, IL-17F, IL-22, and IL23R
during Th17 differentiation is dependent on RORs, there
is little understanding of whether these genes are
regulated directly by RORs. Several studies have
identified the presence of functional ROREs in a 6 kb
promoter flanking region of the IL-17 gene [Ichiyama et
al., 2008;Yang et al., 2008d; Zhang et al., 2008b].
However, there is no consensus on which ROREs are
most important in driving IL-17 expression by RORγt.
Recent studies indicated that the CNS2 region at the
il17-il17f locus (between -4 and -6 kb) undergoes
chromatin remodeling in response to IL-6/TGFβ
[Akimzhanov et al., 2007]. Subsequent studies showed
that the regulation of IL-17 by RORs involves this CNS2
regulatory region [Yang et al., 2008d].This putative
enhancer sequence contains two ROREs that are able
to bind ROR directly and mediate transcriptional activation
by RORα and RORγt, while the 1kb proximal promoter
region was nonresponsive to ROR. ChIP analysis showed
that RORs are associated in vivo with a region containing
the CNS2 site [Yang et al., 2008d].These observations
indicate that the induction of IL-17 by RORs is mediated
through this region and suggest that IL-17 is a direct
target of ROR transcriptional regulation.
In addition to RORs, several other transcription factors,
including STAT3, have been reported to positively
regulate IL17 transcription [Yang et al., 2008d; Zhou et
al., 2007].The induction by STAT3 is mediated through
binding to the promoter region of the IL17 gene.
Expression of constitutively active STAT3 induces IL17
when co-expressed with RORγt, but has little effect in
RORγ-deficient T cells, indicating that the induction of
IL17 expression by STAT3 is dependent on the presence
of RORγt.
Runt-related transcription factor 1 (RUNX1) is another
transcription regulator that promotes Th17 differentiation
by enhancing RORγt and IL17 expression [Zhang et al.,
2008b].The activation of IL17 expression by RUNX1 is
mediated through two Runx-binding sites that are near
the ROREs in the IL17 promoter region. In addition, it
was shown that RUNX1 interacts directly with RORγt and
acts synergistically with RORγt to optimally activate IL17
expression. Expression of FOXP3 inhibits this activation
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repressing their transcriptional activity.
RORs and autoimmune disease
Th17 cells have been implicated in autoimmune disease
and other inflammatory conditions in humans, including
lupus, arthritis, multiple sclerosis, atopic dermatitis,
psoriasis, asthma, and inflammatory bowel disease [Bi
et al., 2007; Huang et al., 2007; Ivanov et al., 2007]. IL-17
induces the secretion of a variety of chemokines,
cytokines, metalloproteinases, and other proinflammatory
mediators and promotes the recruitment of neutrophils.
Mice lacking IL-17 are resistant to collagen-induced
arthritis (CIA) and EAE, a model for multiple sclerosis.
Neutralizing IL-17 with antibodies suppresses CNS
autoimmune inflammation [Dong, 2008;
Furuzawa-Carballeda et al., 2007; Huang et al., 2007;
Korn et al., 2007b; Stockinger et al., 2007]. Inversely,
transfer of Th17 cells aggravates the disease. Rag1
-/-
mice reconstituted with CD4
+ splenocytes or bone marrow
from RORγ- or RORα-deficient mice are less susceptible
to EAE than mice reconstituted with WT CD4
+ splenocytes
or bone marrow [Ivanov et al., 2006;Yang et al., 2008d].
Similar experiments with Rag1
-/- mice reconstituted with
cells from mice deficient in both RORα and RORγ showed
a complete resistance to EAE. Recent studies using the
adoptive transfer model of colitis showed that transfer of
RORγ-null T cells failed to increase mucosal IL-17
cytokine levels and did not induce colitis, while treatment
with IL-17A restored colitis after transfer of RORγ-null T
cells [Leppkes et al., 2009].These studies indicate that
loss of RORα/γt function greatly reduces the susceptibility
to the development of autoimmune disease in mice.
These observations suggest that by controlling Th17
differentiation and IL-17 expression, RORγt and RORα
play a critical role in the regulation of inflammatory
responses (Figure 2).Therefore, RORs might function
as potential drug targets for therapeutic intervention into
autoimmune disease, including chronic colitis and multiple
sclerosis.
RORs and lung inflammation
RORα
sg/sg and RORγ
-/- mice are less susceptible to
ovalbumin (OVA)-induced lung inflammation, which
serves as an experimental model for allergic airway
disease [Jaradat et al., 2006;Tilley et al., 2007].The
infiltration of inflammatory cells, including eosinophils,
neutrophils, and lymphocytes into peribronchiolar and
perivascular regions in lungs and in bronchial alveolar
lavage fluid, was significantly less in OVA-challenged
RORα
sg/sg mice compared to WT mice, and the induction
of Th2 cytokines IL-4, IL-5, and IL-13 was greatly
compromised. Analysis of gene expression profiles
demonstrated that the expression of many genes
implicated in inflammatory responses, including the
chemokines TARC, eotaxin-2 (Ccl24), MIP-1a (Ccl3),
MCP-2 (Ccl8), and RANTES (Ccl5), acute response
proteins, mucins MUC5b and MUC5ac, are induced to a
significantly smaller degree in lungs from OVA-challenged
RORα
sg/sg mice than those from WT mice.Together, these
observations show that RORα
sg/sg mice develop a less
severe allergic inflammatory response. Interestingly,
RORα
sg/sg mice are more susceptible to LPS-induced
inflammation [Stapleton et al., 2005].The mechanism of
this increased sensitivity is not quite yet understood.
The allergic response in RORγ
-/- mice is also severely
impaired, as evidenced by attenuated eosinophilic
pulmonary inflammation and reduction in CD4
+
lymphocytes and level of Th2 cytokines/chemokines
[Tilley et al., 2007]. OVA sensitized and challenged
RORγ
-/- animals showed unexpected increases in TNF-α,
IL-2, IL-10, and IFN-γ and reciprocal reductions in IL-4,
IL-5, and IL-13.This shift in cytokine profiles, coupled
with reduced IgG1 and elevated IgG2c levels in the sera
of OVA-exposed RORγ
-/- mice, reveals a critical role for
RORγ in the regulation of immunoglobulin production and
balance between different T helper cell populations.The
decreased inflammatory response in RORγ
-/- mice might
be in part related to the role RORγ plays in Th17 lineage
determination [Ivanov et al., 2006; Ivanov et al., 2007;
Yang et al., 2008d]. Interestingly, mice lacking IL-17 have
been reported to exhibit an attenuated eosinophilic lung
inflammation and Th2 cytokine production, while IL-10,
which is produced by Treg cells, has been reported to
inhibit allergic inflammation [Umemura et al., 2007; Urry
et al., 2006]. Moreover, mice deficient in the IL17 gene,
but not IL17F, also exhibited reduced Th2 responses in
a similar asthma model [Yang et al., 2008b].Thus, the
reduction in Th17 cells in RORγ
-/- mice and the observed
increase in IFN-γ (Th1) and IL-10 (Treg) in
OVA-challenged RORγ
-/- mice is consistent with the
hypothesis that the decreased susceptibility to allergic
lung inflammation in these mice might be related to shifts
in the commitment to different Th lineages.This
hypothesis is consistent with the concept that crosstalk
between lineage-specific transcription factors plays an
important role in lineage specification.
RORs and circadian rhythm
Circadian behavior of ROR expression
Circadian rhythms are daily cycles of behavioral and
physiological changes that are regulated by endogenous
circadian clocks [Hastings et al., 2007; Isojima et al.,
2003; Ko and Takahashi, 2006; Liu et al., 2007a; Schibler
and Naef, 2005; Schibler and Sassone-Corsi, 2002].The
circadian clock impacts virtually all physiological functions
and behavior. It is therefore not surprising that
abnormalities in circadian rhythm are implicated in an
increasing number of diseases, including sleep and mood
disorders, diabetes, obesity, and cancer [Barnard and
Nolan, 2008; Gery and Koeffler, 2007; Ishida, 2007; Liu
et al., 2007a; Maywood et al., 2006;Turek et al., 2005].
A number of studies have established links between
nuclear receptor function and expression, the circadian
regulatory circuitry, and the regulation of various
physiological processes [Akashi and Takumi, 2005; Duez
and Staels, 2008; Guillaumond et al., 2005; Horard et al.,
2004; Jetten and Joo, 2006; Liu et al., 2008; Preitner et
al., 2003; Ueda et al., 2002b;Yang et al., 2006;Yang et
al., 2007a]. Many nuclear receptors, including RORs,
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expression during the circadian cycle, indicating that their
expression is controlled by the circadian clock. RORα
expression shows a weak circadian oscillation in liver,
kidney, retina, and lung [Akashi and Takumi, 2005;
Kamphuis et al., 2005;Tosini et al., 2007; Ueda et al.,
2002b;Yang et al., 2006]. In the SCN, RORα exhibits a
rhythmic pattern of expression with a peak at CT6-8. A
similar circadian profile was observed for RORβ, while
RORγ is not expressed in the SCN [Schaeren-Wiemers
et al., 1997; Sumi et al., 2002; Ueda et al., 2002b].
RORβ2 displays a rhythmic expression pattern in mouse
pineal gland and retina, with a maximum at CT18 [Andre
et al., 1998a; Ueda et al., 2002b]. RORγ exhibits an
oscillatory expression pattern in liver, brown adipose
tissue, and kidney, but not in skeletal muscle and thymus
[Guillaumond et al., 2005; Jetten and Joo, 2006; Kang et
al., 2007; Ueda et al., 2002b; Ueda et al., 2005;Yang et
al., 2006]. In these tissues, RORγ is expressed at low
levels during the day and at optimum levels at night.
Mice deficient in RORα or RORβ exhibit an aberrant
circadian behavior [Akashi and Takumi, 2005; Masana
et al., 2007; Sato et al., 2004; Schaeren-Wiemers et al.,
1997], while no abnormalities in circadian behavior have
been noticed in RORγ
-/- mice [Liu et al., 2008]. RORα
sg/sg
mice display an anomalous, slightly decreased,
free-running period of locomotor activity and an altered
feeding pattern during the circadian cycle [Akashi and
Takumi, 2005; Guastavino et al., 1991; Sato et al., 2004],
while RORβ
-/- mice display an extended period of
free-running rhythmicity under conditions of constant
darkness [Andre et al., 1998a; Masana et al., 2007].
Regulation of clock genes by ROREs
Nearly every mammalian cell type contains its own
circadian oscillator.The oscillators in peripheral tissues
operate in a self-sustained, cell-autonomous manner
[Isojima et al., 2003; Ko and Takahashi, 2006; Liu et al.,
2007a; Reppert and Weaver, 2001; Reppert and Weaver,
2002; Ripperger and Schibler, 2001; Schibler and
Sassone-Corsi, 2002].Their synchronization is
coordinated by signals originating from the master
circadian clock residing in the SCN of the anterior
hypothalamus.The phase of the master oscillator is set
by the light-dark cycle input received by both visual and
non-visual photoreceptor systems in the retina.
At the molecular level, the clockwork consists of an
integral network of several interlocking negative feedback
and positive feedforward loops.The basic molecular
circuitry of circadian clocks is analogous between tissues.
A major positive loop consists of the basic
helix-loop-helix/PAS-type transcriptional activators BMAL1
and CLOCK or its paralog NPAS2, while two
cryptochrome (CRY) and three period proteins (PER) are
involved in the negative control of the oscillator [Albrecht,
2002; DeBruyne et al., 2007a; DeBruyne et al., 2007b;
Isojima et al., 2003; Reppert and Weaver, 2002; Schibler
and Naef, 2005; Schibler and Sassone-Corsi, 2002]
(Figure 8). BMAL1-CLOCK heterodimers positively
regulate the circadian expression of many genes,
including PER and CRY, through interaction with E-box
enhancers (CACGTG) in the promoter regulatory region
of target genes.When PER and CRY proteins accumulate
to a critical level, they in turn repress
BMAL1:CLOCK-mediated transcription, including their
own transcription, by interacting directly with
BMAL1-CLOCK complexes.This subsequently leads to
reduced levels of PER and CRY protein and to a new
cycle of activation and repression.
The core loop is further regulated by several accessory
pathways, including one in which the D box-binding
proteins, the activator D site-binding protein (DBP) and
the repressor E4 promoter binding-protein 4 (E4BP4 or
NFIL3), play a role, and another that involves regulation
by RORs and REV-ERBs through ROREs [Burris, 2008;
Ko and Takahashi, 2006; Liu et al., 2008; Preitner et al.,
2003; Preitner et al., 2002; Ueda et al., 2005]. ROREs
have been identified in several clock genes, including
BMAL1, CLOCK, and CRY1 [Guillaumond et al., 2005;
Kumaki et al., 2008; Nakajima et al., 2004; Preitner et al.,
2002; Sato et al., 2004; Ueda et al., 2002b].The BMAL1
gene, which contains two ROREs in its promoter region,
is positively regulated by RORs, whereas REV-ERBs
repress BMAL1 transcription (Figure 8). Mutation of these
ROREs abolishes the circadian rhythmicity of the BMAL1
promoter activation, indicating that these response
elements are essential for rhythmic transcriptional
regulation of BMAL1. Further study showed that BMAL1
expression is elevated and its rhythmicity impaired in
fibroblasts deficient in both REV-ERBα and β, but
fibroblasts deficient in only one of the REV-ERB receptors
still retain BMAL1 rhythmicity [Liu et al., 2008].These
observations suggested that REV-ERBα and β are
functionally redundant and essential for the rhythmic
expression of BMAL1. However, REV-ERBα and β are
not required for the rhythmicity of several other clock
genes, including PER and CRY.
In contrast to REV-ERBs, RORs are not required for the
rhythmicity of BMAL1 expression [Liu et al., 2008].
RORα
sg/sg fibroblasts, which lack RORα and do not
express either RORβ or γ, display rhythmic oscillations
of BMAL1 or PER2 promoter-regulated luciferase reporter
expression that are similar to that observed in WT
fibroblasts.These findings are in agreement with studies
showing that the rhythmic expression of various clock
proteins, including PER2, CRY1, BMAL1, and CLOCK,
was not altered in RORα
sg/sg or RORγ null mice [Liu et al.,
2008; Sato et al., 2004]. However, the peak expression
levels of BMAL1, as well as that of several other
RORE-containing clock genes, including CLOCK, CRY1,
and NPAS2, were reduced in both RORα
sg/sg and RORγ
null mice, while those of PER2 and DBP were not
changed. Regulation of BMAL1 by RORs is supported
by findings showing that RORs interact with ROREs in
the BMAL1 promoter and induce transcriptional activation
through this promoter region [Akashi and Takumi, 2005;
Guillaumond et al., 2005; Sato et al., 2004; Ueda et al.,
2005].This activation of BMAL1 expression by RORs
appears to be mediated through the coactivator PGC-1α
[Liu et al., 2007b].Thus, RORs are not essential for the
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Review Physiological functions of RORsFigure 8.  RORs function as integrators of circadian oscillators and the rhythmic expression of downstream (metabolic) genes. The rhythmic
expression of RORs is greatly dependent on the ROR isoform and tissue type.The core loop of the oscillator consists of the heterodimeric activators
BMAL1 and CLOCK that activate the expression of PERs and CRYs. PER and CRY heterodimers interact with the BMAL1-CLOCK complex and
negatively regulate their transcriptional activity. BMAL1 and CLOCK also activate the expression of REV-ERBs, which through their interaction with
ROREs repress the transcription of several genes, including BMAL1, CRY1, and RORγ. REV-ERBs are critical in the rhythmic expression of BMAL1,
CRY1 and RORγ in liver and several other tissues. RORγ does not affect the rhythmic expression, but increases the peak level of expression of BMAL1,
CRY1, NPAS2, CLOCK, and REV-ERBα.The major function of RORγ appears to be to regulate the oscillatory pattern of expression of downstream
target genes and, therefore, the rhythmic nature of several physiological processes. RORα exhibits a very weak rhythmic pattern of expression in liver
and its major function also appears to be in regulating the (rhythmic) expression of downstream target genes. SIRT, through its deacetylase activity,
promotes the degradation of PER and inhibits the interaction of CRY with BMAL1/CLOCK complex, thereby enhancing BMAL1/CLOCK transcriptional
activity.
rhythmic expression of BMAL1 or other clock genes, but
do regulate their level of expression. Moreover, in contrast
to common regulators of the circadian clock, which appear
to be ubiquitously expressed, RORs exhibit a much more
restricted pattern of expression, consistent with the view
that they are not common constituents of clock regulatory
circuitry mechanisms. In addition to modulating the
expression of several components of the circadian clock,
the major function of RORs might be regulating the
rhythmic expression of downstream target genes.
Therefore, RORs may function as intermediates that
couple the circadian oscillators with the cyclic control of
various physiological processes, including energy
homeostasis, lipid, and xenobiotic metabolism [Kang et
al., 2007; Liu et al., 2008; Sato et al., 2004] (Figure 8).
Regulation of circadian expression of RORs
As mentioned above, in several tissues RORs display a
rhythmic expression during the circadian cycle [Liu et al.,
2008; Panda et al., 2002; Sato et al., 2004; Ueda et al.,
2002b; Ueda et al., 2005; Ukai-Tadenuma et al., 2008].
Several functional elements relevant to circadian rhythm
have been identified in the promoter of RORs. Functional
D-boxes were identified in RORα and RORβ, suggesting
regulation by members of the bZIP-family.The proximal
promoter of RORγ1 and RORα1 contain one functional
E-box, while that of RORα4 contains two E-boxes,
suggesting regulation by BMAL1/CLOCK. Based on the
presence of functional ROREs in the promoter regions
of RORs, it was proposed that their expression might be
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in liver and several other tissues the expression of RORγ1
and REV-ERBs is inversely related, is consistent with the
view that REV-ERBs function as repressors of RORγ1
transcription and regulate the rhythmicity of RORγ1
expression (‘repressor-antiphasic-to-activator’
mechanism) [Liu et al., 2008; Ueda et al., 2005;
Ukai-Tadenuma et al., 2008]. RORγ1 appears to have a
minor role in controlling the transcription of REV-ERBs
because their expression is only moderately affected in
liver from RORγ null mice. Analysis of RORγ1 mRNA
expression in liver of BMAL1
-/- mice showed that the
rhythmicity of RORγ1 expression was almost totally
abolished and that RORγ1 expression at all CTs was
greatly elevated [Grechez-Cassiau et al., 2008; Liu et al.,
2008]. It was concluded that, at least in liver, the loss of
REV-ERB repressor expression observed in BMAL1
-/-
mice is likely responsible for the lack of rhythmicity and
relieved or elevated RORγ1 expression in these mice [Liu
et al., 2008]. Expression was particularly increased at
CT6-8, a time at which REV-ERB is normally highly
expressed. How then is RORγ1 transcription activated in
liver of BMAL1
-/- mice? It was suggested that the
expression of RORs might be driven by non-circadian,
tonic signals, such as the cAMP:cAMP response
element-binding (CREB) pathway [Liu et al., 2007a; Liu
et al., 2008; O'Neill et al., 2008].
SIRT1 and RORγ expression
Posttranslational modifications, including phosphorylation
by casein kinases and other kinases and acetylation, play
a critical role in regulating protein-protein interactions,
the nuclear localization, transcriptional activity, and
turnover of clock proteins [Eide et al., 2005; Gallego and
Virshup, 2007; Ko and Takahashi, 2006; Ripperger and
Schibler, 2001]. CLOCK, which functions as a histone
acetyltransferase, has been implicated in chromatin
remodeling during circadian rhythm [Doi et al., 2006]. In
addition to histones, CLOCK also acetylates other
proteins, including BMAL1 [Hirayama et al., 2007].
Recently, sirtuin 1 (SIRT1), a NAD
+-dependent
deacetylase, was identified as an important regulator of
circadian gene expression. It was suggested that it
provides a functional link between metabolic activity and
circadian control [Asher et al., 2008; Belden and Dunlap,
2008; Nakahata et al., 2008]. SIRT1 deacetylates histones
and a number of transcriptional regulators, and was
shown to bind BMAL1-CLOCK-PER2 complexes in a
circadian-dependent manner. SIRT1 catalyzes
deacetylation of PER2, thereby facilitating its degradation
by the proteasome system. Consequently, absence of
SIRT1 expression leads to high levels of PER2, resulting
in diminished BMAL1-CLOCK transcriptional activity and
repression of clock-controlled target genes, including
reduced expression of PER2 and CRY1 (Figure 8). In
addition, SIRT1 induces deacetylation of BMAL1 at Lys
537,
which reduces the efficacy of CRY to interact with and
silence CLOCK-BMAL1 [Nakahata et al., 2008]. Although
RORγ1 is expressed at low levels in mouse embryo
fibroblasts (MEFs), its expression is greatly diminished
in SIRT1 KO MEFs. Because RORγ1 expression is
positively regulated by BMAL1-CLOCK, its repression in
SIRT1 KO MEFs may be related to the silencing of
BMAL1-CLOCK activity. Inversely, the down-regulation
of RORγ1 in SIRT1 KO MEFs may, at least in part,
account for the reduced expression of BMAL1 observed
in these cells.
It has been become increasingly clear that SIRT1
functions as a link between the circadian rhythm circuitry,
cellular metabolism, and nuclear receptors, including
RORs [Asher et al., 2008; Nakahata et al., 2008; Schwer
and Verdin, 2008]. One such link involves PGC-1α. SIRT1
has been reported to induce deacetylation and activation
of PGC-1α, which functions as a coactivator of several
nuclear receptors [Rodgers et al., 2008].This, together
with the circadian regulation of nuclear receptor
expression, is part of the complex mechanism by which
nuclear receptors regulate cellular metabolism. It is
interesting to note that SIRT1 activity peaks around the
same time as RORγ1 mRNA expression (at CT16).
Further studies are needed to elucidate the precise
molecular and physiological connections between SIRT1
and ROR activity.
RORs and cellular metabolism
Changes in lipid metabolism and ROR-deficient
mice
Accumulating evidence indicates that RORs play an
important role in the regulation of several metabolic
pathways, particularly lipid and steroid metabolism
[Boukhtouche et al., 2004; Duez and Staels, 2008;
Genoux et al., 2005; Jetten, 2004; Jetten and Joo, 2006;
Kang et al., 2007; Lau et al., 2008; Lau et al., 2004; Lind
et al., 2005; Mamontova et al., 1998; Raichur et al., 2007;
Raspe et al., 2001;Vu-Dac et al., 1997;Wada et al.,
2008a;Wada et al., 2008b]. RORα
sg/sg mice on a normal
diet display a pronounced hypo-α-lipoproteinemia and
have lower levels of total plasma cholesterol, high density
lipoprotein (HDL), ApoA1, the major constituent of HDL,
ApoC3, ApoA2, and triglycerides compared to WT mice.
The reduced expression of the reverse cholesterol
transporters ABCA1 and ABCA8/G1 in the liver and of
ApoA1 in the intestine may in part be responsible for the
reduced HDL levels. Functional ROREs have been
identified in the promoter regulatory region of APOC2
and APOA1 [Raspe et al., 2001;Vu-Dac et al., 1997].
The RORE within the APOAI promoter was shown to
interact selectively with RORα1, but not with RORα2 or
α3. Although human ApoA5 was identified as a RORα
target gene, its expression was not altered in liver of
RORα
sg/sg mice [Genoux et al., 2005; Lind et al., 2005].
Upon aging, RORα
sg/sg mice are less susceptible to the
development of hepatic steatosis than WT mice [Lau et
al., 2008]. In addition, despite their higher food
consumption, aging RORα
sg/sg mice exhibit a reduced
body fat index. Fat cells in brown and white adipose tissue
are smaller and the level of triglycerides is lower in liver
of RORα
sg/sg mice than WT mice.The increased food
intake correlates with an observed reduction in leptin
expression. As observed for aging RORα
sg/sg mice, 2-3
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sg/sg mice are less susceptible to high
fat diet-induced obesity and steatosis [Lau et al., 2008].
In contrast to RORα
sg/sg mice, cholesterol and triglyceride
levels were unaltered in RORγ
-/- mice; however, these
mice have a somewhat reduced blood glucose level [Kang
et al., 2007]. Mice deficient in both RORα and RORγ
(DKO) exhibit similar changes in cholesterol, triglycerides,
and glucose as observed for single KO mice. Comparison
of gene expression profiles from livers of WT,
RORα-deficient, RORγ-deficient, and DKO mice revealed
that RORα and RORγ can function as positive and
negative regulators of gene expression. In addition to
regulating the expression of a distinct set of genes,
suggesting unique regulatory functions, some genes are
only up- or down-regulated in DKO mice, suggesting a
degree of functional redundancy between RORα and
RORγ [Kang et al., 2007].The latter is likely related to
their similarities in RORE binding affinities. However, the
main functions of RORα and RORγ appear to be distinct
from each other.
RORs in the regulation of (lipid) metabolism
The effect of RORα on triglyceride homeostasis can be
due to the changes in the regulation of a number of
genes, including those involved in the control of
lipogenesis and fatty acid oxidation.The expression of
sterol regulatory element-binding protein 1, isoform c
(SREBP1c), which is a critical regulator of lipogenesis
and several lipogenic genes, was significantly reduced
in liver and skeletal muscle of RORα
sg/sg mice [Lau et al.,
2008;Wada et al., 2008a].This was associated with a
suppression of several SREBP1c target genes, including
fatty acid synthase (FAS). LXRs and carbohydrate
response element-binding protein (ChREBP) have been
reported to be critical factors in the regulation of SREBP1c
[Cha and Repa, 2007; Pegorier et al., 2004;Wagner et
al., 2003]. However, the expression of LXRs and ChREBP
was not significantly altered in liver from RORα
sg/sg mice.
ChIP and promoter analysis indicated that SREBP1c
transcription is under the selective and direct control of
RORα4, the predominant isoform of RORα in liver [Lau
et al., 2008]. It was concluded that RORα positively
regulates lipogenesis through increased SREBP1c
expression.The latter might, at least in part, explain the
reduced adiposity in RORα
sg/sg mice.
The expression of estrogen-related receptor α (ERRα)
and peroxisome proliferators-activated receptors (PPARs)
α, β, and γ, which are implicated in the control of lipid
homeostasis as well, was not changed in RORα
sg/sg mice
[Desvergne et al., 2006;Tremblay and Giguere, 2007].
However, the expression of the coactivators PGC-1α and
β, which are involved in the regulation of oxidative
metabolism and gluconeogenesis, was increased in liver
and brown adipose tissue, respectively [Liu et al., 2008].
Expression of lipin 1, which has multiple functions in lipid
metabolism and glucose homeostasis in several tissues,
was found to be enhanced in liver and adipose tissues
of RORα
sg/sg mice [Lau et al., 2008]. Loss of lipin 1
function leads to hepatic steatosis and
hypertriglyceridemia, but reduced adipose tissue [Peterfy
et al., 2001]. Lipin 1 has been reported to interact directly
with the nuclear receptor PPARα and coactivator PGC-1α
in a complex that modulates fatty acid oxidation gene
expression in hepatocytes [Finck et al., 2006].Thus,
increased levels of PGC-1 and lipin 1 in RORα
sg/sg liver
might enhance oxidative metabolism and account for the
increased expression of acyl-coenzyme A dehydrogenase
ACADM. However, expression of carnitine
palmitoyltransferases 1A and 1B (CPT1A/B), which are
also involved in fatty acid oxidation, was not significantly
affected in liver of RORα
sg/sg mice. Clearly, further studies
are needed to understand the complex relationships
between RORα, its regulation of lipid metabolism, and
its effects on obesity and triglyceride levels.
Regulation of CYP7b1 and sulfotransferases
Several of the genes regulated by RORs encode proteins
involved in Phase I and II enzymes that are important in
the metabolism of xenobiotics, drugs, environmental
chemicals, and various endogeneous compounds,
including steroids and bile acids [Kang et al., 2007;Wada
et al., 2008a].These enzymes play an important role in
elimination and detoxification of endogenous and
exogenous compounds. One of the genes regulated by
RORs is oxysterol 7alpha-hydroxylase (Cyp7b1), which
plays a role in the alternative pathway of cholesterol
metabolism, whereas the expression of Cyp7a1 and
Cyp27, which play a role in the major cholesterol
metabolic pathway, was not affected in ROR-deficient
mice. Cyp7b1, which is preferentially expressed in liver
of male mice, was down-regulated in RORα
sg/sg mice and
was affected only to a small degree in RORγ
-/- mice [Kang
et al., 2007;Wada et al., 2008a]. RORα regulates Cyp7b1
expression directly by binding to an RORE at nt -951 in
the promoter regulatory region of the Cyp7b1 gene.This
RORE preferentially binds RORα rather than RORγ.
These observations suggest that RORα functions as a
positive modulator of Cyp7b1 expression. Recent studies
identified CYP2C8, which play an important role in drug
metabolism, as a putative ROR target gene in human
hepatocytes [Chen et al., 2009]. Both RORα and RORγ
were able to enhance the activation through a RORE
within the CYP2C8 promoter and to enhance CYP2C8
expression in human primary hepatocytes.
Sulfotransferase 1e1 (Sult1e1) is among the genes most
dramatically induced in liver of RORα
sg/sg mice, while the
expression is not significantly changed in RORγ
-/- mice,
suggesting that it is under the selective control of the
RORα signaling pathway [Kang et al., 2007]. Sult1e1
expression in liver is restricted to female mice. It catalyzes
the sulfonation of estrogen and estrone, thereby
increasing their solubility and facilitating their transport
and excretion [Duanmu et al., 2006]. Sult2a1 expression
is induced in liver of both RORα
sg/sg and RORγ
-/- mice,
suggesting that both RORα and RORγ function as
negative modulators of Sult2a1 expression. It catalyzes
the sulfonation of procarcinogens, xenobiotics,
hydroxysteroids, and bile acids, including
dehydroepiandrosterone and lithocholic acid [Kitada et
al., 2003]. In addition to these sulfotransferases, the
expression of several members of the hydroxysteroid
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biosynthesis or inactivation of steroid hormones, are
regulated by RORs [Kang et al., 2007].These
observations suggest that RORs, and particularly RORα,
play an important role in the regulation of specific steps
in bile acid and steroid metabolism.The control of several
sulfotransferases by RORα is interesting with regard to
reports showing that cholesterol sulfate functions as a
ligand of RORα [Kallen et al., 2004; Kallen et al., 2002].
Possibly other sulfated steroid or cholesterol metabolites
might function as high affinity RORα ligands and be part
of regulatory feedback loops that control specific steps
in steroid/cholesterol metabolism.
Several metabolic genes regulated by RORs have been
reported to be target genes of other nuclear receptors
[Akiyama and Gonzalez, 2003; Kalaany and Mangelsdorf,
2006; Kliewer, 2003; Qatanani and Moore, 2005;
Runge-Morris and Kocarek, 2005]. For example, Sult2a1
expression is regulated by several receptors, including
constitutive androstane receptor (CAR), hepatocyte
nuclear factor 4α (HNF4α), and pregnane X receptor
(PXR) [Fang et al., 2007; Maglich et al., 2004]. An overlap
between genes regulated by RORα and liver X receptors
(LXRs) was particularly evident [Gong et al., 2007;Wada
et al., 2008b]. CD36, Sult1e1, and Sult2a1 are induced
while Cyp7b1 expression is inhibited by activated LXR,
a pattern that is the inverse of that observed for RORα
[Kang et al., 2007;Wada et al., 2008a;Wada et al.,
2008b].This raised the possibility of potential crosstalk
between the RORα and LXR pathways. However, this
crosstalk does not occur at the level of the regulation of
LXR or ROR expression because LXRα and β expression
were not altered in liver of RORα
sg/sg mice, while RORα
expression was unchanged in liver of LXR DKO mice
[Lau et al., 2008;Wada et al., 2008a]. Although in cultured
cells, competition between LXR and RORα for binding
common coactivators has been observed, it is not clear
whether such a competition is physiologically significant.
In vivo, the inverse regulation of common targets by
RORα and LXR may involve several mechanisms,
including crosstalk between ROR and LXR transcriptional
complexes bound to their respective response elements
within the promoter of the same target gene.
RORs and muscle
RORα and RORγ mRNA are highly expressed in skeletal
muscle, suggesting a regulatory role for these receptors
in myogenesis or muscle function [Becker-Andre et al.,
1993; Hirose et al., 1994; Lau et al., 1999].This is
supported by observations showing that RORα
sg/sg mice
develop muscular atrophy; however, the mechanism
underlying this phenotype has not been clearly identified.
C2C12 skeletal muscle cells have been used to examine
the function of RORα and RORγ in myogenesis and lipid
homeostasis. Expression of a dominant-negative RORα,
lacking the LBD, delays the morphological differentiation
of myotubes and induction of muscle-specific genes, such
as the helix-loop-helix transcription factors MyoD and
myogenin, transcription factors that are critical for
myotubule differentiation [Lau et al., 1999]. In addition,
the expression of fatty acid translocase (FAT/CD36) and
fatty acid binding protein 3 (FABP3), which are involved
in lipid and fatty acid uptake, and of lipoprotein lipase
(LPL), CPT-1, and acyl-CoA-synthetase-4 (ACS4)
involved in triglyceride hydrolysis and hydroxylation,
respectively, were reduced in these cells [Lau et al.,
2004]. Expression of RORγ in C2C12 cells was shown
to increase the expression of several genes, including
CD36, FABP4, LPL, UCP3, fructose transporter GLUT5,
adiponectin receptor 2 (ADPR2), and IL-15, suggesting
a role for RORγ in the regulation of lipid metabolism in
muscle [Raichur et al., 2007].
RORs and cancer
RORs and increased cancer susceptibility
A number of studies have provided evidence suggesting
a role for RORs in cancer. Mice deficient in the expression
of RORγ exhibit a high incidence of thymic lymphomas
that metastasize frequently to liver and spleen [Jetten
and Ueda, 2002; Ueda et al., 2002a]. As a consequence,
the lifespan of RORγ null mice is greatly reduced.The
enhanced lymphoma formation may be related to changes
in thymic homeostasis observed in RORγ KO mice
[Kurebayashi et al., 2000; Sun et al., 2000]. Although the
molecular mechanism underlying enhanced lymphoma
formation has not yet been established, it may be related
to the dysregulation of differentiation and proliferation in
RORγ
-/- thymocytes. Interestingly, type B leukemogenic
virus (TBLV), which causes T-cell lymphomas in mice,
was found to be frequently integrated at the RORγ locus
[Broussard et al., 2004]. However, in contrast to RORγ
null mice, RORγ expression correlated positively with
lymphomas.Whether RORγ is implicated in human
lymphomas requires further study.
Another potential link between RORγ and cancer is
emerging from studies showing increased expression of
Th17-associated genes, including RORγ, IL-17, and IL-23,
in gastric tumors, an increase in the population of
circulating Th17 cells in gastric cancer patients [Zhang
et al., 2008a], and a high incidence of Th17 cells at sites
of ovarian cancer [Miyahara et al., 2008].These elevated
levels of proinflammatory cytokines may contribute to
cancer pathogenesis. Alterations in RORγt expression or
activity may cause changes in the Th17 cell population
and production of proinflammatory cytokines, thereby
affecting cancer progression positively or negatively.
Although no explicit links between RORα and cancer
have been established, a number of studies have
indicated a possible a role for RORα in cancer
development.The RORα gene spans a 730 kb genomic
region that is located in the middle of the common fragile
site FRA15A within chromosomal band 15q22.2 [Smith
et al., 2006; Zhu et al., 2006]. Common fragile sites are
highly unstable genomic regions found in all individuals
and are hotspots for deletions and other genetic
alterations that may lead to altered expression and
function of genes encoded within these regions. Common
fragile sites have been implicated in several human
diseases and are associated with a number of different
cancer types [Smith et al., 2006]. Genomic instability
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of RORα and play a role in the development of certain
cancers.This hypothesis is consistent with observations
showing that RORα mRNA expression is often
down-regulated in tumor cell lines and primary cancer
samples [Zhu et al., 2006]. Moreover, studies examining
gene expression profiles in various cancers identified
RORα as a gene commonly down-regulated in several
tumor types, particularly breast and lung cancer [Lu et
al., 2007]. Analysis of the methylation status of a series
of genes identified RORα as one of methylation-silenced
genes in gastric cancer cell lines [Yamashita et al., 2006].
The latter is in agreement with the concept that reduced
expression of RORα expression positively correlates with
tumor formation.
RORs, hypoxia and stress
Several studies have revealed a connection between
RORα expression and hypoxia. Hypoxia is important in
normal physiology and in several pathologies, including
ischemia, stroke, heart attack, chronic kidney disease,
and cancer progression [Pouyssegur et al., 2006;
Semenza, 2000]. Oxygen sensing is a key control
mechanism of vasculogenesis and tumor growth. Hypoxia
triggers a multifaceted cellular response in which the
transcription factor hypoxia-inducible factor HIF-1α plays
a central role. Several studies have reported that RORα4,
but not RORα1, expression is highly induced under
hypoxic conditions in a variety of cell types [Besnard et
al., 2002; Chauvet et al., 2004; Chauvet et al., 2002; Miki
et al., 2004]. Conditions that mimic effects of hypoxia,
including exposure to cobalt chloride and the iron chelator,
desferrioxamine, also enhance RORα4 expression
[Chauvet et al., 2002]. In addition to hypoxia, several
other stress conditions induce RORα4 expression,
including H2O2 and several inducers of endoplasmic
reticulum (ER) stress, including farnesol, thapsigargin,
tunicamycin, and brefeldin [Joo et al., 2007; Zhu et al.,
2006].These observations indicate a regulatory role for
RORα4 in hypoxia and stress responses. Studies in vivo
demonstrated that ischemia-induced angiogenesis was
enhanced in RORα-deficient mice [Besnard et al., 2001].
These observations suggest that RORα functions as an
important negative modulator of angiogenesis.
Angiogenesis is controlled by pro- and anti-angiogenic
factors. Inflammatory cells and cytokines have also been
implicated in the regulation of angiogenesis.Thus,
changes in the expression of pro- and/or anti-angiogenic
or inflammatory genes in RORα
sg/sg mice might account
for the observed increased angiogenesis.The expression
of the pro-angiogenic vascular endothelial growth factor
(VEGF) was not changed in ischemia-induced
angiogenesis in RORα
sg/sg mice; however, the level of
interleukin 12 (IL-12), an anti-angiogenic cytokine, was
found to be reduced. Clearly, additional studies are
needed to understand the role of RORα in angiogenesis.
The induction of RORα4 expression by hypoxia is
mediated by HIF-1α through an interaction with a hypoxia
response element (HRE) in the proximal promoter region
of RORα4 [Chauvet et al., 2004]. Subsequent studies
showed that activation of RORα4 by hypoxia was
dependent on an interaction between HIF-1α and the
transcription factors Sp1/Sp3 bound to GC-rich sequences
adjacent to the HRE [Miki et al., 2004]. Recently,
exogenous expression of RORα was reported to increase
the level of HIF1α and VEGF protein, while knockdown
of RORα expression by siRNAs reduced HIF1α and
VEGF expression [Kim et al., 2008]. Moreover, RORα
was found to enhance capillary tube formation by human
umbilical vein endothelial cells.These observations
suggest that RORα may function as an amplifier of
HIF1α-mediated responses by hypoxia. RORα was
reported to stimulate hypoxia response element
(HRE)-dependent transcriptional activation of a reporter.
The enhancement in HIF1α-mediated transactivation by
RORα was found to be related to increased stability of
HIF-1α protein and to involve a direct interaction between
HIF-1α and the DBD of RORα [Kim et al., 2008]. Several
of the experiments in this study were based on activation
of RORα by melatonin, a rather controversial putative
ligand of RORα.Thus, additional studies are needed to
understand the role of RORα and melatonin in hypoxia.
RORα1 and RORγ1 have also been implicated in other
stress-related regulatory functions. RORα1 has been
reported to provide protection to oxidative stress-induced
apoptosis in cortical neurons by increasing the expression
of antioxidant proteins glutathione peroxidase 1 (GPX1)
and peroxiredoxin 6 (Prx6), thereby reducing the
accumulation of stress-related reactive oxygen species
(ROS) [Boukhtouche et al., 2006b]. Ectopic expression
of RORγ in C2C12 cells has been reported to enhance
UCP3 expression and decrease ROS production [Raichur
et al., 2007]. Identification of genes regulated by RORα
might shed light on its precise role in hypoxia- and
stress-induced responses.
Summary
Recent studies of RORs have greatly widened our
understanding of the physiological roles of this nuclear
receptor subfamily and provided exciting clues about their
critical functions in embryonic development, cellular
differentiation and proliferation, immunity, cellular
metabolism, and circadian rhythm.The rhythmic pattern
of expression of RORs in certain tissues and the
regulation of several components of the circadian clock
and metabolic pathways by RORs are consistent with the
emerging view that the controls of these processes are
coupled. RORs function as a subcomponent of the
circadian oscillator and integrate the control of the
circadian clocks and the rhythmic pattern of expression
of (metabolic) genes and, as such, regulate the cyclic
nature of several physiological processes, including
energy homeostasis, lipid and xenobiotic metabolism.
The reduced susceptibility of RORα-deficient mice to
hepatic steatosis and obesity suggests a role for RORα
in energy homeostasis.The critical regulatory roles that
RORs have in thymopoiesis, development of several
secondary lymphoid tissues, and Th17 lineage
specification are highly relevant to a variety of immune
responses and inflammatory disorders, including
autoimmune diseases and asthma.The greatly decreased
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autoimmune encephalomyelitis, and colitis in
ROR-deficient mice raises the possibility that RORs might
serve as potential novel targets for chemotherapeutic
strategies to intervene in these disease processes.The
discovery that ROR activity can be modulated by ligands
strongly supports this prospect. Hopefully, the next
decade will see the discovery of ROR-specific,
clinically-useful (ant)agonists.
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